Glycemic variability in diagnosis of gestational diabetes as predictor of pharmacological treatment | Endocrinología, Diabetes y Nutrición (English ed.)

array:24 ["pii" => "S253001802400026X" "issn" => "25300180" "doi" => "10.1016/j.endien.2024.03.010" "estado" => "S300" "fechaPublicacion" => "2024-03-01" "aid" => "1453" "copyright" => "SEEN and SED" "copyrightAnyo" => "2024" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Endocrinol Diabetes Nutr. 2024;71:96-102" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S2530016424000016" "issn" => "25300164" "doi" => "10.1016/j.endinu.2023.12.007" "estado" => "S300" "fechaPublicacion" => "2024-03-01" "aid" => "1453" "copyright" => "SEEN y SED" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Endocrinol Diabetes Nutr. 2024;71:96-102" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "Original" "titulo" => "Variabilidad glucémica al diagnóstico de diabetes gestacional como predictor de tratamiento farmacológico" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "96" "paginaFinal" => "102" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Glycemic variability in diagnosis of gestational diabetes as predictor of pharmacological treatment" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 978 "Ancho" => 1341 "Tamanyo" => 84800 ] ] "descripcion" => array:1 [ "es" => "Curva ROC para CONGA y tratamiento farmacológico." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rosa Márquez-Pardo, María-Gloria Baena-Nieto, Juan-Antonio Córdoba-Doña, Concepción Cruzado-Begines, Lourdes García-García-Doncel, Manuel Aguilar-Diosdado, Isabel-María Torres-Barea" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Rosa" "apellidos" => "Márquez-Pardo" ] 1 => array:2 [ "nombre" => "María-Gloria" "apellidos" => "Baena-Nieto" ] 2 => array:2 [ "nombre" => "Juan-Antonio" "apellidos" => "Córdoba-Doña" ] 3 => array:2 [ "nombre" => "Concepción" "apellidos" => "Cruzado-Begines" ] 4 => array:2 [ "nombre" => "Lourdes" "apellidos" => "García-García-Doncel" ] 5 => array:2 [ "nombre" => "Manuel" "apellidos" => "Aguilar-Diosdado" ] 6 => array:2 [ "nombre" => "Isabel-María" "apellidos" => "Torres-Barea" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S253001802400026X" "doi" => "10.1016/j.endien.2024.03.010" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S253001802400026X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530016424000016?idApp=UINPBA00004N" "url" => "/25300164/0000007100000003/v1_202403120547/S2530016424000016/v1_202403120547/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S2530018024000313" "issn" => "25300180" "doi" => "10.1016/j.endien.2024.03.014" "estado" => "S300" "fechaPublicacion" => "2024-03-01" "aid" => "1461" "copyright" => "The Author(s)" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Endocrinol Diabetes Nutr. 2024;71:103-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Original article" "titulo" => "An effective insulin infusion protocol for severe traumatic brain injury patients: A retrospective observational study" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "103" "paginaFinal" => "109" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estudio de observación retrospectiva de un programa eficaz de infusión de insulina para el tratamiento de pacientes con lesión craneoencefálica grave" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1878 "Ancho" => 3341 "Tamanyo" => 355538 ] ] "descripcion" => array:1 [ "en" => "The new insulin infusion protocol for sTBI patients. 1. The protocol mainly consists of the following steps: (A) Categorization of patients based on the first blood glucose measurement into three groups: hypoglycaemia (<4.4mmol/L), acceptable glycaemic range (4.4–10.0mmol/L), and hyperglycaemia (>10.0mmol/L). (B) Hypoglycaemia management process: Hypoglycaemic patients enter the hypoglycaemia management process directly, which includes appropriate interventions such as adjusting nutrition support and insulin dosage to correct the low blood glucose levels. (C) Retesting of blood glucose for patients in acceptable glycaemic range and hyperglycaemia to confirm the need for insulin infusion. (D) Hyperglycaemia management process: Patients with sustained hyperglycaemia for two consecutive blood glucose tests enter the hyperglycaemia management process. Depending on whether nutritional support is provided, an initial insulin bolus may be required, and the insulin maintenance dosage is adjusted according to the range of blood glucose changes. (E) Insulin dosage adjustment with changes in nutritional support: Insulin dosage is reduced when nutritional support is discontinued, with the reduction amount being dependent on the use of enteral or parenteral nutrition. (2) Blood sampling: For patients using vasoactive medications, we collect arterial blood from an arterial line. For other patients, we use capillary blood samples. (3) Monitoring frequency: We employ intermittent blood glucose monitoring, typically every 2h (q2h). If the blood glucose remains within the target range (7.8–10.0mmol/L) continuously for 24h, the frequency is changed to every 4h (q4h). In cases of hypoglycaemia, the monitoring frequency may be increased, such as every 15min (q15min) or every hour (q1h). The doctor has the authority to increase the blood glucose monitoring frequency based on the specific condition of the patient. (4) The protocol is not suitable for oral intake patients." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jie Chen, Bingbing Ye, Feng Lin, Wenchao Cai, Rui Chen, Zhanwei Ruan" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Jie" "apellidos" => "Chen" ] 1 => array:2 [ "nombre" => "Bingbing" "apellidos" => "Ye" ] 2 => array:2 [ "nombre" => "Feng" "apellidos" => "Lin" ] 3 => array:2 [ "nombre" => "Wenchao" "apellidos" => "Cai" ] 4 => array:2 [ "nombre" => "Rui" "apellidos" => "Chen" ] 5 => array:2 [ "nombre" => "Zhanwei" "apellidos" => "Ruan" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530018024000313?idApp=UINPBA00004N" "url" => "/25300180/0000007100000003/v2_202405192240/S2530018024000313/v2_202405192240/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2530018024000258" "issn" => "25300180" "doi" => "10.1016/j.endien.2024.03.009" "estado" => "S300" "fechaPublicacion" => "2024-03-01" "aid" => "1440" "copyright" => "SEEN and SED" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Endocrinol Diabetes Nutr. 2024;71:93-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Editorial" "titulo" => "New formulations of levothyroxine in the treatment of hypothyroidism" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "93" "paginaFinal" => "95" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Nuevas formulaciones de levotiroxina en el tratamiento del hipotiroidismo" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Pedro Iglesias" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Pedro" "apellidos" => "Iglesias" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S2530016423002252" "doi" => "10.1016/j.endinu.2023.11.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530016423002252?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530018024000258?idApp=UINPBA00004N" "url" => "/25300180/0000007100000003/v2_202405192240/S2530018024000258/v2_202405192240/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "Original article" "titulo" => "Glycemic variability in diagnosis of gestational diabetes as predictor of pharmacological treatment" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "96" "paginaFinal" => "102" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Rosa Márquez-Pardo, María-Gloria Baena-Nieto, Juan-Antonio Córdoba-Doña, Concepción Cruzado-Begines, Lourdes García-García-Doncel, Manuel Aguilar-Diosdado, Isabel-María Torres-Barea" "autores" => array:7 [ 0 => array:4 [ "nombre" => "Rosa" "apellidos" => "Márquez-Pardo" "email" => array:1 [ 0 => "rosa_marquez_pardo@hotmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "María-Gloria" "apellidos" => "Baena-Nieto" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Juan-Antonio" "apellidos" => "Córdoba-Doña" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "Concepción" "apellidos" => "Cruzado-Begines" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 4 => array:3 [ "nombre" => "Lourdes" "apellidos" => "García-García-Doncel" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 5 => array:3 [ "nombre" => "Manuel" "apellidos" => "Aguilar-Diosdado" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] 6 => array:3 [ "nombre" => "Isabel-María" "apellidos" => "Torres-Barea" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Servicio de Endocrinología y Nutrición, Hospital Juan Ramón Jiménez, Huelva, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Endocrinología y Nutrición, Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio de Endocrinología y Nutrición, Hospital Universitario Puerta del Mar, Cádiz, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Variabilidad glucémica al diagnóstico de diabetes gestacional como predictor de tratamiento farmacológico" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 977 "Ancho" => 1341 "Tamanyo" => 87725 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "ROC curve for CONGA and pharmacological treatment." ] ] ] "textoCompleto" => "IntroductionGestational diabetes mellitus (GDM) is an intolerance of carbohydrates diagnosed in the second or third semester of pregnancy, with no clear evidence of previous diabetes mellitus.<a class="elsevierStyleCrossRef" href="#bib0005">1</a> It is prevalent in about 8.8% of total gestations (1%–12%).<a class="elsevierStyleCrossRef" href="#bib0010">2</a> Hyperglycemia in pregnancy is related to greater risk of maternal complications (hypertension induced by pregnancy, pre-eclampsia, intrauterine fetal death, caesarean section birth) and fetal complications (hypoglycemia, hyperbilirubinemia, macrosomia, obstetric traumatism).<a class="elsevierStyleCrossRef" href="#bib0015">3</a> In addition, it involves a greater risk of developing type 2 diabetes mellitus (DM) and metabolic syndrome with an increase in incidence of cardiovascular diseases.<a class="elsevierStyleCrossRefs" href="#bib0020">4,5</a>GDM treatment aims to maintain glycemia levels within a very narrow range similar to that of gestation without diabetes. It includes hygienic dietary measures and, if these have no effect, pharmacological treatment.<a class="elsevierStyleCrossRef" href="#bib0030">6</a>In common clinical practice, glucose levels are measured by self-monitoring of capillary glycemia (SMCG), however, nowadays continuous glucose monitoring (CGM) systems can measure the glucose of the interstitial fluid using an electrochemical method that makes a good correlation between the glucose calculated at interstitial level and in the blood.<a class="elsevierStyleCrossRef" href="#bib0035">7</a> There are also real-time, blind or retrospective sensors, the latter used by professionals as a diagnostic-therapeutic tool to modify DM patients’ treatment.<a class="elsevierStyleCrossRef" href="#bib0040">8</a>Studies using CGM are rare in GDM, involving few patients and frequently analyzing them alongside women with both pre-gestational and gestational DM. Nevertheless, these few studies have shown that CGM systems detect hyperglycemia more frequently than SMCG.<a class="elsevierStyleCrossRefs" href="#bib0045">9,10</a> Also, the use of both real-time and retrospective CGM is associated to better glycemia control than when SMCG is applied, and to less weight gain in both mother and newborn. Yet there is no evidence of a reduction in other maternal-fetal complications related to GDM.<a class="elsevierStyleCrossRefs" href="#bib0055">11,12</a> Recent years have seen an increase in the study of GV parameters using CGM, describing higher GV in women with GDM.<a class="elsevierStyleCrossRefs" href="#bib0065">13,14</a> However, in the retrospective use of CGM in GDM, the GV data obtained as a predictive tool for the onset of obstetric and perinatal complications have provided mixed results.<a class="elsevierStyleCrossRef" href="#bib0075">15</a>In GDM treatment, hygienic dietary measures have been shown to reduce excess weight in newborns, and there has been a drop in maternal-fetal complications when pharmacological treatment is administered.<a class="elsevierStyleCrossRefs" href="#bib0080">16–18</a> In terms of CGM in GDM and pharmacological treatment, some studies have shown that when CGM is used, more patients start pharmacological treatment than when only SMCG is used.<a class="elsevierStyleCrossRef" href="#bib0095">19</a> However, so far no study has analyzed the use of CGM following GDM diagnosis to detect GV parameters and their relation to the probability of requiring pharmacological treatment.The aim of our study was to use CGM, on diagnosis of GDM, to establish whether mean glycemia levels and GV parameters can help predict the probability of a patient requiring pharmacological treatment, and whether these parameters are related to the development of obstetric and perinatal complications.Materials and methodsPatientsThis is a prospective study of GDM patients at the Endocrinology and Pregnancy Department of the University Hospital of Jerez, Spain. The inclusion period ran from February 2016 to June 2018. This hospital provides coverage to 456,000 inhabitants, with an average of 2421 term pregnancies a year.The study included pregnant women between weeks 26 and 32 of gestation diagnosed with GDM using the two-step strategy, and an oral glucose overload of 100 g with two abnormally high values, in line with diagnostic criteria of the National Diabetes Data Group and the 3rd Workshop-Conference on Gestational Diabetes Mellitus, which are: basal glucose 105 mg/dL, 190 mg/dL at 60 minutes, 165 mg/dL at 120 minutes, and 145 mg/dl at 180 minutes.<a class="elsevierStyleCrossRef" href="#bib0100">20</a> Excluded from the study were those patients with pre-gestational diabetes, chronic systemic illnesses, an acute infectious process and/or refusal to give informed consent.In the first visit following GDM diagnosis, data were obtained from the patient on race, age, gestation stage, family history of DM and personal GDM antecedents, obstetric history, pre-gestational body mass index (pBMI) and the following analytical parameters: glucose, HbA1c, uric acid, triglycerides, HDL and LDL cholesterol.After completing gestation, data were gathered on GDM treatment and maternal complications during gestation, such as hypertension induced by pregnancy (systolic arterial pressure ≥140 mm Hg or diastolic arterial pressure ≥90 mm Hg after 20 weeks of gestation), pre-eclampsia (hypertension induced by pregnancy, with proteinuria ≥30 mg/mmol creatinine), type of birth (ectopic, instrumental delivery or caesarean). The data on newborns included their weight at birth, neonatal complications such as being small for gestational age (SGA) (percentile <10), large for gestational age (LGA) (percentile >90), macrosomia (weight >4000 g), hypoglycemia (less than 40 mg/dl in the first 24 hours), hyperbilirubinemia, traumatism, infection and length of stay in ICU.Hygienic dietary measuresIn the first visit, all patients were given advice on diet and a personalized plan based on their pBMI: if this was less than 18.5 kg/m2, the dietary allowance was between 36–40 kcal/kg/day, 31–35 kcal/kg/day at 18.5–25 kg/m2, 25–30 kcal//kg/day at 25–29 kg/m2, and 23–25 kcal/kg/day if higher than 30 kg/m2. The macronutrient distribution was 40%–50% carbohydrates, 30%–40% fat and 20% proteins.<a class="elsevierStyleCrossRef" href="#bib0030">6</a>Monitoring of glucose and treatmentIn the first visit, according to routine clinical practice, each woman was given a capillary glycemia monitoring device (Contour® next) to perform SMCG before, and 1 hour after, breakfast, lunch and dinner. The marked glycemic targets follows the American Diabetes Association guidelines of ≤95 mg/dl before eating, ≤140 mg/dl 1 hour after.<a class="elsevierStyleCrossRef" href="#bib0105">21</a> If this score was exceeded, pharmacological treatment was started, with insulin as the medium of choice in our setting for treatment by gestating mothers.<a class="elsevierStyleCrossRef" href="#bib0030">6</a> Hypoglycemia was defined as a value of glucose <70 mg/dl.The first visit also included implanting a blind or retrospective CGM device in each patient (model iPro™2) that they would wear for 6 consecutive days. The sensor was inserted into the subcutaneous tissue and linked to a transmitter attached to the skin. This device records and stores 288 glucose measurements continuously over 24 hours, and the data are downloaded for later assessment. The parameters analyzed were: mean glycemia as centralized measurement and mean GV, standard deviation (SD), coefficient variance (CV), mean amplitude of glycemic excursions (MAGE), mean of daily differences (MODD) and continuous overlapping of net glycemic action in a period of n-hours (CONGAn). CV is defined as the SD divided by the glucose mean, its interpretation expressed in percentage terms; MAGE is defined as the arithmetic mean of glucose values from the lowest to the highest points or vice versa; MODD is defined as the mean of the differences between glucose values at the same time of day over two consecutive days, allowing the analysis of GV between different days, and, CONGA, is the standard deviation of the sum of differences between a given value and the observed values in the previous hours (n), which enables the analysis of GV over a 24-h period.This study was approved by the Research Ethics Committee of the province of Cadiz in line with the ethical principles set out in the Helsinki Declaration. Prior to inclusion in the study, all patients wishing to participate signed an informed consent form.Statistical analysisIn the descriptive analysis, the results of the quantitative variables were expressed in terms of mean and standard deviation, and in frequencies and percentages for the qualitative variables.A multivariate analysis was performed using logistic regression models, taking as dependent variables each result for obstetrics and newborns; independent variables were mean glycemia, SD, CV, MAGE, MODD and CONGAn, with age and pBMI used in the models as adjustment variables. Then, an analysis was made of the need for treatment, as a dependent variable, as well as using as the GV parameters mentioned as independent variables, and adjusting for age and pBMI. When the variables associated to the need for pharmacological treatment had been identified (mean glycemia and CONGAn), the area below the ROC curve was calculated for both variables. A statistically significant association was confirmed if the p-value was less than 0.05. The Stata program version 16 was used to gather and analyze the data. The GV parameters were calculated with EasyGV software.<a class="elsevierStyleCrossRefs" href="#bib0110">22,23</a>ResultsClinical characteristics, anthropometric and analytical parametersThe study initially included 87 patients with GDM, but 10 were excluded due to problems with the sensor (sensor damage or incomplete data transfer). The analysis was carried out on 77 gestating mothers, of whom 75 (97.4%) were classified as Caucasian, 1 (1.4%), Asian and 1 (1.4%) Hispanic American. The mean age was 33.5 ± 4.23 years (30 patients [38.9%] were aged 35 or over). GDM diagnosis was made at 30.2 ± 2.16 of gestation. DM family antecedents were present in 51 (66.2%) of the patients. Of all the patients analyzed, 54 (70.1%) had had one or more prior pregnancies, and of these 15 (27.7%) had presented with GDM in previous pregnancies. The anthropometric and analytical parameters are presented in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>.<elsevierMultimedia ident="tbl0005"></elsevierMultimedia>Evolution of gestation, birth and maternal-fetal complicationsDuring gestation, 18 (23.4%) patients required pharmacological treatment with insulin, administered in accordance with our area’s action protocol.<a class="elsevierStyleCrossRef" href="#bib0030">6</a> On average, treatment with insulin began in week 31 of gestation, requiring a total insulin dose (ID) of 16.8 ± 13.72 (IU) corresponding to 0.25 units per kilo of weight required per day (ID/kg/day). The type of insulin required was 33% basal, 33% rapid acting analog, and 33% combined basal and rapid acting analog. The most frequent time to administer insulin was before the 3 main meals of the day (n = 8, 44.4%), then at around dinner time (n = 5, 27.7%); less frequent administration occurred at breakfast and lunch (n = 2, 11.1%), lunch and dinner (n = 1. 5.5%) and breakfast (n = 1. 5.5%).Regarding maternal complications during pregnancy, 2 (2.6%) women developed gestational hypertension but none pre-eclampsia; 44 (57.1%) patients had an ectopic birth, 8 (10.4%) an instrumental delivery and 25 (32.5%) were by caesarean.In the perinatal results, the mean weight of the newborn was 3281.7 ± 460.68 grams (percentile 56.39 ± 30.58), 5 (6.5%) were SGA, 14 (18.2%) LGA and 10 (13%) had macrosomia. A total of 17 (22.1%) newborns experienced a hypoglycemic episode, 6 (7.8%) hyperbilirubinemia, 6 (7.8%) required oxygen therapy support, 1 (1.3%) suffered an obstetric traumatism, 1 (2.3%) was born with an infection, and 3 (3.9%) were admitted to ICU.Continuous glucose monitoring<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> presents the GV parameters based on the results from retrospective CGM over 6 consecutive days. As observed in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>, no relation was found between the various GV parameters and the obstetric and perinatal results.<elsevierMultimedia ident="tbl0010"></elsevierMultimedia>When assessing the relation between pharmacological treatment and GV parameters obtained from the CGM, we observe that when mean glycemia and CONGAn levels are high, the probability of the patient requiring pharmacological treatment increases with OR = 1.24 for mean glycemia (95% confidence interval [110–1.40]; p < 0.001]) and OR = 1.22 for CONGAn (95% confidence interval [1.09–1.37]; p = 0.001]). Thus, if we describe the data in terms of averages, we observe that for each mg/dL increase in mean glycemia and CONGAn, there is a rise of 24% and 22% respectively in the probability of the patient requiring pharmacological treatment (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).In terms of the capacity to predict the need for pharmacological treatment based on CGM data, the cut-off points for mean glycemia and CONGAn can be calculated with greater sensitivity (S) and specificity (E), with scores of 98.81 mg/dL (S 83.3%, E 67.8%) and 86.70 mg/dL (S 83.3%, E 67.8%), respectively (<a class="elsevierStyleCrossRefs" href="#fig0005">Figs. 1 and 2</a>).<elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia>ConclusionThe GV parameters obtained from CGM quantify the amplitude, frequency and duration of glycemic fluctuations in a way that provides very useful information to add to that acquired by classic methods such as preprandial and postprandial glycemia readings from SMCG and HbA1c. For this reason, GV is increasingly important in the control of type 1 and 2 DM, as it has demonstrated that the time and amplitude of glucose fluctuations imply greater risk of hyperglycemia and hypoglycemia. GV itself is also known to represent a risk factor for diabetes-related complications.<a class="elsevierStyleCrossRefs" href="#bib0120">24,25</a>In recent years, CGM studies on GDM have also begun measuring GV parameters and analyzing their relation to maternal-fetal complications. Given the scarcity of such studies, there are still no established standardized GV reference values for GDM as there are for DM.<a class="elsevierStyleCrossRefs" href="#bib0130">26–30</a> Another drawback is disparity in the results and the difficulty in comparing them, as they do not always analyze the same GV parameters<a class="elsevierStyleCrossRefs" href="#bib0130">26–28</a>; in addition, the parameters are determined at different stages of gestation and different software programs are used in the calculations<a class="elsevierStyleCrossRef" href="#bib0115">23</a>; our study used the EasyGV software.<a class="elsevierStyleCrossRefs" href="#bib0110">22,23</a> Yet although it is difficult to compare our results to those in other published studies, it can be stated that the majority present GV values that are higher than those obtained in our work.<a class="elsevierStyleCrossRefs" href="#bib0130">26–30</a>Dietary treatment is the first therapeutic step, and has been shown to reduce excess weight in newborns associated to GDM.<a class="elsevierStyleCrossRef" href="#bib0155">31</a> Adequate glycemic control is achieved in 70%–85% of cases, thus avoiding the need for pharmacological treatment. The results in our study show that 23.4% of gestating mothers needed pharmacological treatment with insulin, similar to that described in the literature.<a class="elsevierStyleCrossRef" href="#bib0030">6</a> In patients who failed to reach the glycemia objectives by dietary treatment, pharmacological treatment helps to reduce maternal-fetal complications,<a class="elsevierStyleCrossRef" href="#bib0155">31</a> so it is essential to identify as soon as possible those patients who will probably need to it.According to the latest data, there are still no studies that aim to assess the relation between mean glycemia and GV after the diagnosis of GDM and the probability of requiring pharmacological treatment during the pregnancy. Our study is the first to show that mean glycemia, as a centralized measurement, and CONGAn, as a GV parameter, both obtained by CGM after the diagnosis of GDM, can help predict the need for pharmacological treatment. In this way, we observe that for each mg/dL increase in mean glycemia and CONGAn, there is a rise of 24% and 22% respectively in the probability of the patient requiring pharmacological treatment.The results of our work enable us to establish cut-off points for mean glycemia and CONGAn with a high degree of sensitivity and specificity (<a class="elsevierStyleCrossRefs" href="#fig0005">Figs. 1 and 2</a>). GDM patients require highly sensitive tests in order for medical professionals to intensify therapeutic measures quickly to prevent or minimize maternal-fetal complications. Those patients detected with GDM via CGM with a mean glycemia above 98.81 mg/dL and/or CONGAn higher than 86.70 mg/dL should be monitored more closely. Thus, it is possible to predict from diagnosis which patients will go on to require pharmacological treatment.Another important finding in this work is the absence of any relation between the data for mean glycemia and GV obtained in GDM diagnosis and the development of maternal-fetal complications. Several works have analyzed GV in GDM with different results. One study of women with GDM in the third trimester corroborates our results, as it did not find that CGM was a predictor of the development of complications in the mother or newborn, though the number of patients included in the study was less than in ours.<a class="elsevierStyleCrossRef" href="#bib0140">28</a> By contrast, another study shows a direct relation between GV and fetal growth in patients with type 1 diabetes and GDM (at different stages of gestation) but it analyzed only a small number of patients, thus interpretation of the results is fairly inconsistent.<a class="elsevierStyleCrossRef" href="#bib0135">27</a> A more recent prospective observational study of GDM patients between weeks 30–32 of gestation showed a direct proportional relation between mean glycemia and LGA.<a class="elsevierStyleCrossRef" href="#bib0150">30</a> In our study, CGM was applied directly after diagnosing GDM, and the patients received appropriate pharmacological treatment during monitoring, with the consequent optimization of glycemic control yielding a reduction of the effect on the fetus and development of complications.The novel aspect of this work is to demonstrate the potential usefulness of CGM on diagnosis of GDM as a tool that can identify a specific group of patients who would benefit from closer monitoring of mean glycemia and CONGAn, and the cut-off points with high sensitivity. So far, there is no published work that assesses GV via CGM in the meaning presented in this study. It also has the added value of homogeneity in the sample characteristics and the acceptable number of patients included. The results obtained can be transferred to populations with characteristics similar to those in our sample, although to extrapolate them would require future studies to recruit more patients.One of the limitations of this study is the small number of patients included, which can undermine the strength of this work to assess the potential relation to low-incidence obstetric and newborn results, though this is still stronger than in the majority of works in the literature. Another potential weakness is that compliance with dietary measures was irregular among the patients, which could have affected the measurements as it is difficult to assess adherence to dietary advice. Nevertheless, this is unlikely to have had a significant effect since this is a highly homogeneous population with similar dietary habits marked by custom and place of residence.In conclusion, the use of CGM after GDM diagnosis can predict the probability of requiring pharmacological treatment in patients who present higher mean glycemia and CONGAn scores. In this way, CGM could identify those patients who would benefit from closer monitoring during gestation, using SMCG in order to start pharmacological treatment as soon as a possible. It would be interesting for future prospective studies to assess the efficiency of CGM, that is, to be able to show a reduction in maternal-fetal complications and associated costs in order for its use to be recommended following GDM diagnosis.Conflict of interestThe authors declares that they have no conflict of interest." "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:3 [ "identificador" => "xres2149173" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Materials and methods" ] 2 => array:2 [ "identificador" => "abst0011" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0015" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1824150" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres2149174" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0020" "titulo" => "Objetivo" ] 1 => array:2 [ "identificador" => "abst0025" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0030" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0035" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1824151" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Materials and methods" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Patients" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Hygienic dietary measures" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Monitoring of glucose and treatment" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Statistical analysis" ] ] ] 6 => array:3 [ "identificador" => "sec0035" "titulo" => "Results" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0040" "titulo" => "Clinical characteristics, anthropometric and analytical parameters" ] 1 => array:2 [ "identificador" => "sec0045" "titulo" => "Evolution of gestation, birth and maternal-fetal complications" ] 2 => array:2 [ "identificador" => "sec0050" "titulo" => "Continuous glucose monitoring" ] ] ] 7 => array:2 [ "identificador" => "sec0055" "titulo" => "Conclusion" ] 8 => array:2 [ "identificador" => "sec0065" "titulo" => "Conflict of interest" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2023-08-28" "fechaAceptado" => "2023-12-28" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1824150" "palabras" => array:5 [ 0 => "Continuous glucose monitoring" 1 => "Glycemic variability" 2 => "Gestational diabetes mellitus" 3 => "Pharmacological treatment" 4 => "Maternal-fetal complications" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1824151" "palabras" => array:5 [ 0 => "Monitorización continua de glucosa" 1 => "Variabilidad glucémica" 2 => "Diabetes mellitus gestacional" 3 => "Tratamiento farmacológico" 4 => "Complicaciones materno-fetales" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "IntroductionTo establish whether glycemic variability (GV) parameters used when gestational diabetes mellitus (GDM) has been diagnosed could help predict the probability that a patient will need pharmacological treatment, and to analyze the link of these parameters to the development of maternal-fetal complications. Materials and methodsA prospective study of 87 women with GDM who underwent retrospective continuous glucose monitoring (CGM) for six days between weeks 26 and 32 of gestation, following diagnosis. The mean glycemia levels and GV variables were analyzed together with their link to maternal-fetal complications, and the need for pharmacological treatment. ROC (receiver operating characteristic) curves were developed to determine validity to detect the need for pharmacological treatment. ResultsPatients with higher mean glycemia (p < 0.001) and continuous overlapping of net glycemic action in a period of n-hours (CONGAn) (p = 0.001) required pharmacological treatment. The ROC curves showed cut-off points of 98.81 mg/dL for mean glycemia, and 86.70 mg/dL for CONGAn, with 83.3% sensitivity and 67.8% specificity for both parameters. No relation between the GV parameters and development of maternal-fetal complications was observed. ConclusionsThe use of CGM, once GDM is diagnosed, enables us to identify those patients who would benefit from closer monitoring during gestation, and facilitate a speedier take-up of pharmacological treatment. However, prospective studies involving a higher number of patients are needed, as well as a cost assessment for recommending the use of CGM following GDM diagnosis." "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Materials and methods" ] 2 => array:2 [ "identificador" => "abst0011" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0015" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "ObjetivoEstablecer si determinados parámetros de variabilidad glucémica (VG) al diagnóstico de Diabetes Mellitus gestacional (DMG) podrían ayudar a predecir la probabilidad de precisar tratamiento farmacológico y analizar la relación de estos con el desarrollo de complicaciones materno-fetales. MétodosEstudio prospectivo en 87 mujeres con DMG a las que se realiza una monitorización continua de glucosa (MCG) retrospectiva entre la 26-32 semana de gestación durante 6 días, tras el diagnóstico. Se analizan glucemia media y parámetros de VG y su asociación con complicaciones materno-fetales y necesidad de tratamiento farmacológico. Se elaboran curvas ROC para estimar la validez para detectar la necesidad de tratamiento farmacológico. ResultadosLas pacientes con glucemia media más elevada (p < 0.001) y solapamiento continuo de la acción de la glucosa en un periodo de n-horas (CONGA) (p = 0.001) precisaron tratamiento farmacológico. A partir de las curvas ROC se obtuvieron los puntos de corte de 98.81 mg/dL para glucemia media y de 86.70 mg/dL para CONGA con una sensibilidad de 83.3%% y especificidad de 67.8% para ambos parámetros. No se observó una relación entre los distintos parámetros de VG y el desarrollo de complicaciones materno-fetales. ConclusionesEl uso de la MCG al diagnóstico de la DMG permite identificar a aquellas pacientes que se beneficiarían de una vigilancia más estrecha durante la gestación, facilitando el inicio de un tratamiento farmacológico precoz. No obstante, son necesarios estudios prospectivos con un mayor número de pacientes y que evalúen los costes asociados para poder recomendar el uso de la MCG tras el diagnóstico de DMG." "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0020" "titulo" => "Objetivo" ] 1 => array:2 [ "identificador" => "abst0025" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0030" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0035" "titulo" => "Conclusiones" ] ] ] ] "multimedia" => array:4 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 917 "Ancho" => 1258 "Tamanyo" => 78850 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "ROC curve for mean glycemia and pharmacological treatment." ] ] 1 => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 977 "Ancho" => 1341 "Tamanyo" => 87725 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "ROC curve for CONGA and pharmacological treatment." ] ] 2 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Variables \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Value (mean ± SD) \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Pregestation weight (kg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">69.6 ± 12.46 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Pregestation BMI (kg/m2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">26.2 ± 4.75 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Pregestation obesity (BMI > 30 kg/m2) % \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">17 (22) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Weight gain \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8.1 ± 5.14 kg \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral glucose overload 50 g 60 min (mg/dl) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">172.3 ± 19.73 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral glucose overload 100 g 0 min (mg/dl) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">80.9 ± 11.47 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral glucose overload 100 g 60 min (mg/dl) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">193.8 ± 22.45 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral glucose overload 100 g 120 min (mg/dl) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">180.1 ± 22.03 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral glucose overload 100 g 180 min (mg/dl) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">146.6 ± 29.88 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Total cholesterol (mg/dl) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">243.3 ± 43.14 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">LDL cholesterol (mg/dl) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">151.9 ± 43.84 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HDL cholesterol HDL (mg/dl) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">68.4 ± 26.89 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Triglycerides (mg/dl) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">211.4 ± 68.75 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Uric acid (mg/dl) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4.1 ± 3.65 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HbA1c% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5.1 ± 0.33 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Mean \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">97.4 ± 8.40 mg/dl \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">19.6 ± 4.30 mg/dl \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CV \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">20.1 ± 4.30 % \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">MAGE \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">44.2 ± 13.43 mg/dl \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">MODD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">19.7 ± 5.39 mg/dl \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CONGA \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">85.8 ± 7.69 mg/dl \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3541891.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Analytical & anthropometric parameters." ] ] 3 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0020" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Treatment \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Caesarean \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Macrosomia \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">LGA \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Hypoglycemia \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Mean \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.24 [0.09–0.34]<0.001 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.98 [0.93–1.05]p = 0.739 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.03 [0.95–1.13]p = 0.398 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.07 [0.99–1.16]p = 0.104 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[0.93–1.07]p = 0.935 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.11 [−0.03 to 0.25]p = 0.121 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.96 [0.85–1.08]p = 0.477 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.96 [0.81–1.13]p = 0.629 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.04 [0.90–1.19]p = 0.579 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.99 [0.86–1.13]p = 0.839 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CV \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.99 [0.86–1.14]p = 0.890 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.96 [0.84–1.09]p = 0.540 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.93 [0.79–1.11]p = 0.444 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[0.88–1.16]p = 0.970 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.98 [0.85 – 1.12]p = 0.743 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">MAGE \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.03 [−0.01 to 0.07]p = 0.176 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.99 [0.95–1.03]p = 0.612 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.99 [0.94–1.05]p = 0.943 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.03 [0.98–1.08]p = 0.197 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.99 [0.96–1.04]p = 0.900 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">MODD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.96 [−0.01 to 0.20]p = 0.075 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.95 [0.85–1.04]p = 0.294 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.98 [0.86–1.12]p = 0.790 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[0.93–1.15]p = 0.556 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.96 [0.86–1.07]p = 0.503 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">CONGA \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.22 [0.08–0.31]p = 0.001 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.99 [0.93–1.07];p = 0.990 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.04 [0.94–1.14]p = 0.425 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.07 [0.98–1.16]p = 0.144 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">[0.93–1.08]p = 0.879 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3541890.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Logistic regression analysis of the association between GV and maternal-fetal complications and treatment with insulin. Odds ratio (confidence interval 95%), p-value." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:31 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Classification and diagnosis of diabetes: standards of medical care in diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "American Diabetes Association Professional Practice Committee. 2" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Diabetes Care" "fecha" => "2023" "volumen" => "46" "numero" => "Supplement 1" "paginaInicial" => "S2" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Potential impact of American Diabetes Association (2000) criteria for diagnosis of gestational diabetes mellitus in Spain" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W. Ricart" 1 => "J. López" 2 => "J. Mozas" 3 => "A. Pericot" 4 => "M.A. Sancho" 5 => "N. González" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00125-005-1756-9" "Revista" => array:7 [ "tituloSerie" => "Diabetologia" "fecha" => "2005" "volumen" => "48" "numero" => "6" "paginaInicial" => "1135" "paginaFinal" => "1141" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15889233" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "W. Ye" 1 => "C. Lou" 2 => "J. Huang" 3 => "C. Li" 4 => "Z. Liu" 5 => "F. Liu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj-2021-067946" "Revista" => array:4 [ "tituloSerie" => "BMJ" "fecha" => "2022" "volumen" => "25" "numero" => "377" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gestational diabetes melltus and long-term consequences for mother and offspring: a view fron Denbark" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P. Damm" 1 => "A. Houshmand-Oeragaard" 2 => "L. Kelstraup" 3 => "J. Lauenborg" 4 => "E.R. Mathiesen" 5 => "T.D. Clausen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00125-016-3985-5" "Revista" => array:6 [ "tituloSerie" => "Diabetologia" "fecha" => "2016" "volumen" => "59" "paginaInicial" => "1396" "paginaFinal" => "1399" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27174368" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W.L Lowe" 1 => "D.M Scholtens" 2 => "L.P Lowe" 3 => "A. Kuang" 4 => "O. Nodzenski" 5 => "O Talbot" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2018.11628" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2018" "volumen" => "320" "paginaInicial" => "1005" "paginaFinal" => "1016" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30208453" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diabetes mellitus gestacional proceso de atención integrado [Internet]" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Forcada-Falcón" 1 => "L. Aceituno-Velasco" 2 => "D. Acosta-Delgado" 3 => "L. Arribas-Mir" 4 => "P. Aznarte-Padial" 5 => "C. Candela-Gómez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "WWW" => array:2 [ "link" => "http://red.pidma.es/file.php/1/Doc_Apoyo_Diabetes_Gestacionalv7.pdf" "fecha" => "2019" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sistema de monitorización continua de glucosa: una nueva herramienta para mejorar el control metabólico de los pacientes diabéticos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Chico" 1 => "M. Subirà" 2 => "A. Novials" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Endocrinol Nutr" "fecha" => "2001" "volumen" => "48" "numero" => "9" "paginaInicial" => "266" "paginaFinal" => "271" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:1 [ "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "titulo" => "Monitorización continua de glucosa y monitorización flash de glucosa" "fecha" => "2019" "editorial" => "Sociedad Española de Diabetes" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Continuous glucose monitoring during pregnancy complicated by gestational diabetes mellitus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "L. Jovanovic" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11892-001-0015-9" "Revista" => array:7 [ "tituloSerie" => "Curr Diab Rep" "fecha" => "2001" "volumen" => "1" "numero" => "1" "paginaInicial" => "82" "paginaFinal" => "85" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12762962" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Introductory experience with the continuous glucose monitoring system (CGMS; Medtronic Minimed) in detecting hyperglycemia by comparing the self-monitoring of blood glucose (SMBG) in non-pregnant women and in pregnant women with impaired glucose tolerance and gestational diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.J. Bühling" 1 => "B. Kurzidim" 2 => "C. Wolf" 3 => "K. Wohlfarth" 4 => "M. Mahmoudi" 5 => "C. Wäscher" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1055/s-2004-830399" "Revista" => array:7 [ "tituloSerie" => "Exp Clin Endocrinol Diabetes" "fecha" => "2004" "volumen" => "112" "numero" => "10" "paginaInicial" => "556" "paginaFinal" => "560" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15578329" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of continuous glucose monitoring on maternal and neonatal outcomes in perinatal women with diabetes: a systematic reviedw and meta-analysis de randomized controlled trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "V.Y. Chang" 1 => "Y.L Tan" 2 => "W.H.D Ang" 3 => "Y. Lau" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Diabetes Res Clin Pract" "fecha" => "2021" "volumen" => "184" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of continous glucose monitoring on glycaemic cotrol in pregnant women with gestational diabetes mellitus- a systematic review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Majewska" 1 => "P.J. Stanrowski" 2 => "M. Wielgos" 3 => "C. Bomba-Opos" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/jcm11071932" "Revista" => array:5 [ "tituloSerie" => "J Clin Med" "fecha" => "2022" "volumen" => "11" "paginaInicial" => "1932" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35407540" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Measuring glucose exposure and variability using continuous glucose monitoring in normal and abnormal glucose metabolism in pregnancy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R. Mazze" 1 => "Y. Yogev" 2 => "O. Langer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/14767058.2012.670413" "Revista" => array:7 [ "tituloSerie" => "J Matern Fetal Neonatal Med" "fecha" => "2012" "volumen" => "25" "numero" => "7" "paginaInicial" => "1171" "paginaFinal" => "1175" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22384865" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Glycemic variability in gestacional diabetes mellitus and its assotiacion wit b cell function" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J.B. Su" 1 => "X.Q. Wang" 2 => "J.F. Chen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12020-012-9753-5" "Revista" => array:7 [ "tituloSerie" => "Endocrine" "fecha" => "2013" "volumen" => "43" "numero" => "2" "paginaInicial" => "370" "paginaFinal" => "375" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22815046" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A review of research progress of glycemic variability and gestational diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Y. Wenshu" 1 => "W. Na" 2 => "L. Ling" 3 => "U. Jong" 4 => "Q. Meichen" 5 => "S. Haitao" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Diabetes Metab Synd Obes" "fecha" => "2020" "volumen" => "13" "paginaInicial" => "2729" "paginaFinal" => "2741" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R. Martis" 1 => "C.A. Crowther" 2 => "E. Shepherd" 3 => "J. Alsweiler" 4 => "M.R. Downie" 5 => "J. Brown" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD012327.pub2" "Revista" => array:3 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2018" "numero" => "8" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of treatment of gestational diabetes mellitus on pregnancy outcomes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.A. Crowther" 1 => "J.E. Hiller" 2 => "J.R. Moss" 3 => "A.J. McPhee" 4 => "W.S. Jeffries" 5 => "J.S. Robinson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa042973" "Revista" => array:7 [ "tituloSerie" => "N Engl J Med" "fecha" => "2005" "volumen" => "352" "numero" => "24" "paginaInicial" => "2477" "paginaFinal" => "2486" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15951574" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A multicenter, randomized trial of treatment for mild gestational diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.B. Landon" 1 => "C.Y. Spong" 2 => "E. Thom" 3 => "M.W. Carpenter" 4 => "S.M. Ramin" 5 => "B. Casey" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa0902430" "Revista" => array:7 [ "tituloSerie" => "N Engl J Med" "fecha" => "2009" "volumen" => "361" "numero" => "14" "paginaInicial" => "1339" "paginaFinal" => "1348" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19797280" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "K.K. Kestilä" 1 => "U.U. Ekblad" 2 => "T. Rönnemaa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.diabres.2006.12.012" "Revista" => array:7 [ "tituloSerie" => "Diabetes Res Clin Pract" "fecha" => "2007" "volumen" => "77" "numero" => "2" "paginaInicial" => "174" "paginaFinal" => "179" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17234297" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Asistencia a la gestante con diabetes. Guía de práctica clínica actualizada en 2014" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Grupo Espanol ˜ de Diabetes y Embarazo (GEDE)" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Av Diabetol" "fecha" => "2015" "volumen" => "31" "numero" => "2" "paginaInicial" => "45" "paginaFinal" => "59" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of diabetes in pregnancy: standards of medical care in diabetes—2023" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Association AD. 15" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Diabetes Care" "fecha" => "2023" "volumen" => "46" "numero" => "Supplement 1" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "N.R. Hill" 1 => "N.S. Oliver" 2 => "P. Choudhary" 3 => "J.C. Levy" 4 => "P. Hindmarsh" 5 => "D.R. Matthews" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/dia.2010.0247" "Revista" => array:7 [ "tituloSerie" => "Diabetes Technol Ther" "fecha" => "2011" "volumen" => "13" "numero" => "9" "paginaInicial" => "921" "paginaFinal" => "928" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21714681" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Differences in the mean amplitude of glycemic excursions calculated by two automated methods" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P.I. Beato-Víbora" 1 => "F.J. Arroyo-Díez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/dia.2013.0195" "Revista" => array:7 [ "tituloSerie" => "Diabetes Technol Ther" "fecha" => "2014" "volumen" => "16" "numero" => "2" "paginaInicial" => "123" "paginaFinal" => "124" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24160691" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L. Monnier" 1 => "C. Colette" 2 => "D.R. Owens" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/193229680800200618" "Revista" => array:7 [ "tituloSerie" => "J Diabetes Sci Technol" "fecha" => "2008" "volumen" => "2" "numero" => "6" "paginaInicial" => "1094" "paginaFinal" => "1100" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19885298" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "F. Picconi" 1 => "A. Di Flaviani" 2 => "I. Malandrucco" 3 => "I. Giordani" 4 => "S. Frontoni" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.numecd.2012.03.006" "Revista" => array:7 [ "tituloSerie" => "Nutr Metab Cardiovasc Dis" "fecha" => "2012" "volumen" => "22" "numero" => "9" "paginaInicial" => "691" "paginaFinal" => "696" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22673768" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Yu" 1 => "L. Lv" 2 => "Z. Liang" 3 => "Y. Wang" 4 => "J. Wen" 5 => "X. Lin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2013-4332" "Revista" => array:7 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2014" "volumen" => "99" "numero" => "12" "paginaInicial" => "4674" "paginaFinal" => "4682" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25057872" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Glucose variability in diabetic pregnancy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.G. Dalfrà" 1 => "G. Sartore" 2 => "G. Di Cianni" 3 => "G. Mello" 4 => "C. Lencioni" 5 => "S. Ottanelli" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/dia.2010.0145" "Revista" => array:7 [ "tituloSerie" => "Diabetes Technol Ther" "fecha" => "2011" "volumen" => "13" "numero" => "8" "paginaInicial" => "853" "paginaFinal" => "859" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21751862" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Correlation between third trimester glycemic variability in non-insulin-dependent gestational diabetes mellitus and adverse pregnancy and fetal outcomes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "W.S. Panyakat" 1 => "C. Phatihattakorn" 2 => "A. Sriwijitkamol" 3 => "P. Sunsaneevithayakul" 4 => "A. Phaophan" 5 => "A. Phichitkanka" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1932296817752374" "Revista" => array:7 [ "tituloSerie" => "J Diabetes Sci Technol" "fecha" => "2018" "volumen" => "12" "numero" => "3" "paginaInicial" => "622" "paginaFinal" => "629" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29320884" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Glucose fluctuations during gestation: an additional tool for monitoring pregnancy complicated by diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.G. Dalfrà" 1 => "N.C. Chilelli" 2 => "G. Di Cianni" 3 => "G. Mello" 4 => "C. Lencioni" 5 => "S. Biagioni" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Int J Endocrinol" "fecha" => "2013" "volumen" => "2013" ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Suboptimal nocturnal glucose control is associated with large for gestational age in treated gestational diabetes mellitus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "G.R. Law" 1 => "A. Alnaji" 2 => "L. Alrefaii" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc18-2212" "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "2019" "volumen" => "42" "paginaInicial" => "810" "paginaFinal" => "815" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30765428" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lifestyle interventions for the treatment of women with gestational diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Brown" 1 => "N.A. Alwan" 2 => "J. West" 3 => "S. Brown" 4 => "C.J. McKinlay" 5 => "D. Farrar" ] ] ] ] ] "host" => array:2 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2017" "volumen" => "5" ] ] 1 => array:1 [ "WWW" => array:1 [ "link" => "https://ws003.juntadeandalucia.es:3071/cdsr/doi/10.1002/14651858.CD011970.pub2/abstract" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/25300180/0000007100000003/v2_202405192240/S253001802400026X/v2_202405192240/en/main.assets" "Apartado" => array:4 [ "identificador" => "64496" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/25300180/0000007100000003/v2_202405192240/S253001802400026X/v2_202405192240/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S253001802400026X?idApp=UINPBA00004N"]

Statistics

Original article

Glycemic variability in diagnosis of gestational diabetes as predictor of pharmacological treatment

Variabilidad glucémica al diagnóstico de diabetes gestacional como predictor de tratamiento farmacológico

Rosa Márquez-Pardoa,

Corresponding author

rosa_marquez_pardo@hotmail.com

Corresponding author.

, María-Gloria Baena-Nietob, Juan-Antonio Córdoba-Doñab, Concepción Cruzado-Beginesb, Lourdes García-García-Doncelb, Manuel Aguilar-Diosdadoc, Isabel-María Torres-Bareac

a Servicio de Endocrinología y Nutrición, Hospital Juan Ramón Jiménez, Huelva, Spain

b Servicio de Endocrinología y Nutrición, Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Spain

c Servicio de Endocrinología y Nutrición, Hospital Universitario Puerta del Mar, Cádiz, Spain

Read

Times
was read the article

Total PDF

Total HTML

Share statistics

 array:24 [
  "pii" => "S253001802400026X"
  "issn" => "25300180"
  "doi" => "10.1016/j.endien.2024.03.010"
  "estado" => "S300"
  "fechaPublicacion" => "2024-03-01"
  "aid" => "1453"
  "copyright" => "SEEN and SED"
  "copyrightAnyo" => "2024"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "fla"
  "cita" => "Endocrinol Diabetes Nutr. 2024;71:96-102"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S2530016424000016"
      "issn" => "25300164"
      "doi" => "10.1016/j.endinu.2023.12.007"
      "estado" => "S300"
      "fechaPublicacion" => "2024-03-01"
      "aid" => "1453"
      "copyright" => "SEEN y SED"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "fla"
      "cita" => "Endocrinol Diabetes Nutr. 2024;71:96-102"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:1 [
        "total" => 0
      ]
      "es" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
        "titulo" => "Variabilidad gluc&#233;mica al diagn&#243;stico de diabetes gestacional como predictor de tratamiento farmacol&#243;gico"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "96"
            "paginaFinal" => "102"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Glycemic variability in diagnosis of gestational diabetes as predictor of pharmacological treatment"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0010"
            "etiqueta" => "Figura 2"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr2.jpeg"
                "Alto" => 978
                "Ancho" => 1341
                "Tamanyo" => 84800
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Curva ROC para CONGA y tratamiento farmacol&#243;gico&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Rosa M&#225;rquez-Pardo, Mar&#237;a-Gloria Baena-Nieto, Juan-Antonio C&#243;rdoba-Do&#241;a, Concepci&#243;n Cruzado-Begines, Lourdes Garc&#237;a-Garc&#237;a-Doncel, Manuel Aguilar-Diosdado, Isabel-Mar&#237;a Torres-Barea"
            "autores" => array:7 [
              0 => array:2 [
                "nombre" => "Rosa"
                "apellidos" => "M&#225;rquez-Pardo"
              ]
              1 => array:2 [
                "nombre" => "Mar&#237;a-Gloria"
                "apellidos" => "Baena-Nieto"
              ]
              2 => array:2 [
                "nombre" => "Juan-Antonio"
                "apellidos" => "C&#243;rdoba-Do&#241;a"
              ]
              3 => array:2 [
                "nombre" => "Concepci&#243;n"
                "apellidos" => "Cruzado-Begines"
              ]
              4 => array:2 [
                "nombre" => "Lourdes"
                "apellidos" => "Garc&#237;a-Garc&#237;a-Doncel"
              ]
              5 => array:2 [
                "nombre" => "Manuel"
                "apellidos" => "Aguilar-Diosdado"
              ]
              6 => array:2 [
                "nombre" => "Isabel-Mar&#237;a"
                "apellidos" => "Torres-Barea"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S253001802400026X"
          "doi" => "10.1016/j.endien.2024.03.010"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S253001802400026X?idApp=UINPBA00004N"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530016424000016?idApp=UINPBA00004N"
      "url" => "/25300164/0000007100000003/v1_202403120547/S2530016424000016/v1_202403120547/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2530018024000313"
    "issn" => "25300180"
    "doi" => "10.1016/j.endien.2024.03.014"
    "estado" => "S300"
    "fechaPublicacion" => "2024-03-01"
    "aid" => "1461"
    "copyright" => "The Author&#40;s&#41;"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Endocrinol Diabetes Nutr. 2024;71:103-9"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "An effective insulin infusion protocol for severe traumatic brain injury patients&#58; A retrospective observational study"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "103"
          "paginaFinal" => "109"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Estudio de observaci&#243;n retrospectiva de un programa eficaz de infusi&#243;n de insulina para el tratamiento de pacientes con lesi&#243;n craneoencef&#225;lica grave"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1878
              "Ancho" => 3341
              "Tamanyo" => 355538
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">The new insulin infusion protocol for sTBI patients&#46; 1&#46; The protocol mainly consists of the following steps&#58; &#40;A&#41; Categorization of patients based on the first blood glucose measurement into three groups&#58; hypoglycaemia &#40;&#60;4&#46;4<span class="elsevierStyleHsp" style=""></span>mmol&#47;L&#41;&#44; acceptable glycaemic range &#40;4&#46;4&#8211;10&#46;0<span class="elsevierStyleHsp" style=""></span>mmol&#47;L&#41;&#44; and hyperglycaemia &#40;&#62;10&#46;0<span class="elsevierStyleHsp" style=""></span>mmol&#47;L&#41;&#46; &#40;B&#41; Hypoglycaemia management process&#58; Hypoglycaemic patients enter the hypoglycaemia management process directly&#44; which includes appropriate interventions such as adjusting nutrition support and insulin dosage to correct the low blood glucose levels&#46; &#40;C&#41; Retesting of blood glucose for patients in acceptable glycaemic range and hyperglycaemia to confirm the need for insulin infusion&#46; &#40;D&#41; Hyperglycaemia management process&#58; Patients with sustained hyperglycaemia for two consecutive blood glucose tests enter the hyperglycaemia management process&#46; Depending on whether nutritional support is provided&#44; an initial insulin bolus may be required&#44; and the insulin maintenance dosage is adjusted according to the range of blood glucose changes&#46; &#40;E&#41; Insulin dosage adjustment with changes in nutritional support&#58; Insulin dosage is reduced when nutritional support is discontinued&#44; with the reduction amount being dependent on the use of enteral or parenteral nutrition&#46; &#40;2&#41; Blood sampling&#58; For patients using vasoactive medications&#44; we collect arterial blood from an arterial line&#46; For other patients&#44; we use capillary blood samples&#46; &#40;3&#41; Monitoring frequency&#58; We employ intermittent blood glucose monitoring&#44; typically every 2<span class="elsevierStyleHsp" style=""></span>h &#40;q2h&#41;&#46; If the blood glucose remains within the target range &#40;7&#46;8&#8211;10&#46;0<span class="elsevierStyleHsp" style=""></span>mmol&#47;L&#41; continuously for 24<span class="elsevierStyleHsp" style=""></span>h&#44; the frequency is changed to every 4<span class="elsevierStyleHsp" style=""></span>h &#40;q4h&#41;&#46; In cases of hypoglycaemia&#44; the monitoring frequency may be increased&#44; such as every 15<span class="elsevierStyleHsp" style=""></span>min &#40;q15min&#41; or every hour &#40;q1h&#41;&#46; The doctor has the authority to increase the blood glucose monitoring frequency based on the specific condition of the patient&#46; &#40;4&#41; The protocol is not suitable for oral intake patients&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jie Chen, Bingbing Ye, Feng Lin, Wenchao Cai, Rui Chen, Zhanwei Ruan"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Jie"
              "apellidos" => "Chen"
            ]
            1 => array:2 [
              "nombre" => "Bingbing"
              "apellidos" => "Ye"
            ]
            2 => array:2 [
              "nombre" => "Feng"
              "apellidos" => "Lin"
            ]
            3 => array:2 [
              "nombre" => "Wenchao"
              "apellidos" => "Cai"
            ]
            4 => array:2 [
              "nombre" => "Rui"
              "apellidos" => "Chen"
            ]
            5 => array:2 [
              "nombre" => "Zhanwei"
              "apellidos" => "Ruan"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530018024000313?idApp=UINPBA00004N"
    "url" => "/25300180/0000007100000003/v2_202405192240/S2530018024000313/v2_202405192240/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2530018024000258"
    "issn" => "25300180"
    "doi" => "10.1016/j.endien.2024.03.009"
    "estado" => "S300"
    "fechaPublicacion" => "2024-03-01"
    "aid" => "1440"
    "copyright" => "SEEN and SED"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Endocrinol Diabetes Nutr. 2024;71:93-5"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "New formulations of levothyroxine in the treatment of hypothyroidism"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "93"
          "paginaFinal" => "95"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Nuevas formulaciones de levotiroxina en el tratamiento del hipotiroidismo"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Pedro Iglesias"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Pedro"
              "apellidos" => "Iglesias"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S2530016423002252"
        "doi" => "10.1016/j.endinu.2023.11.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530016423002252?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2530018024000258?idApp=UINPBA00004N"
    "url" => "/25300180/0000007100000003/v2_202405192240/S2530018024000258/v2_202405192240/en/main.assets"
  ]
  "en" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
    "titulo" => "Glycemic variability in diagnosis of gestational diabetes as predictor of pharmacological treatment"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "96"
        "paginaFinal" => "102"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Rosa M&#225;rquez-Pardo, Mar&#237;a-Gloria Baena-Nieto, Juan-Antonio C&#243;rdoba-Do&#241;a, Concepci&#243;n Cruzado-Begines, Lourdes Garc&#237;a-Garc&#237;a-Doncel, Manuel Aguilar-Diosdado, Isabel-Mar&#237;a Torres-Barea"
        "autores" => array:7 [
          0 => array:4 [
            "nombre" => "Rosa"
            "apellidos" => "M&#225;rquez-Pardo"
            "email" => array:1 [
              0 => "rosa_marquez_pardo@hotmail.com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Mar&#237;a-Gloria"
            "apellidos" => "Baena-Nieto"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Juan-Antonio"
            "apellidos" => "C&#243;rdoba-Do&#241;a"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Concepci&#243;n"
            "apellidos" => "Cruzado-Begines"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Lourdes"
            "apellidos" => "Garc&#237;a-Garc&#237;a-Doncel"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Manuel"
            "apellidos" => "Aguilar-Diosdado"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "Isabel-Mar&#237;a"
            "apellidos" => "Torres-Barea"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Servicio de Endocrinolog&#237;a y Nutrici&#243;n&#44; Hospital Juan Ram&#243;n Jim&#233;nez&#44; Huelva&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Endocrinolog&#237;a y Nutrici&#243;n&#44; Hospital Universitario de Jerez de la Frontera&#44; Jerez de la Frontera&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Servicio de Endocrinolog&#237;a y Nutrici&#243;n&#44; Hospital Universitario Puerta del Mar&#44; C&#225;diz&#44; Spain"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Variabilidad gluc&#233;mica al diagn&#243;stico de diabetes gestacional como predictor de tratamiento farmacol&#243;gico"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 977
            "Ancho" => 1341
            "Tamanyo" => 87725
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0010"
            "detalle" => "Figure "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">ROC curve for CONGA and pharmacological treatment&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Gestational diabetes mellitus &#40;GDM&#41; is an intolerance of carbohydrates diagnosed in the second or third semester of pregnancy&#44; with no clear evidence of previous diabetes mellitus&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> It is prevalent in about 8&#46;8&#37; of total gestations &#40;1&#37;&#8211;12&#37;&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> Hyperglycemia in pregnancy is related to greater risk of maternal complications &#40;hypertension induced by pregnancy&#44; pre-eclampsia&#44; intrauterine fetal death&#44; caesarean section birth&#41; and fetal complications &#40;hypoglycemia&#44; hyperbilirubinemia&#44; macrosomia&#44; obstetric traumatism&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> In addition&#44; it involves a greater risk of developing type 2 diabetes mellitus &#40;DM&#41; and metabolic syndrome with an increase in incidence of cardiovascular diseases&#46;<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4&#44;5</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">GDM treatment aims to maintain glycemia levels within a very narrow range similar to that of gestation without diabetes&#46; It includes hygienic dietary measures and&#44; if these have no effect&#44; pharmacological treatment&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">In common clinical practice&#44; glucose levels are measured by self-monitoring of capillary glycemia &#40;SMCG&#41;&#44; however&#44; nowadays continuous glucose monitoring &#40;CGM&#41; systems can measure the glucose of the interstitial fluid using an electrochemical method that makes a good correlation between the glucose calculated at interstitial level and in the blood&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> There are also real-time&#44; blind or retrospective sensors&#44; the latter used by professionals as a diagnostic-therapeutic tool to modify DM patients&#8217; treatment&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Studies using CGM are rare in GDM&#44; involving few patients and frequently analyzing them alongside women with both pre-gestational and gestational DM&#46; Nevertheless&#44; these few studies have shown that CGM systems detect hyperglycemia more frequently than SMCG&#46;<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9&#44;10</span></a> Also&#44; the use of both real-time and retrospective CGM is associated to better glycemia control than when SMCG is applied&#44; and to less weight gain in both mother and newborn&#46; Yet there is no evidence of a reduction in other maternal-fetal complications related to GDM&#46;<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11&#44;12</span></a> Recent years have seen an increase in the study of GV parameters using CGM&#44; describing higher GV in women with GDM&#46;<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">13&#44;14</span></a> However&#44; in the retrospective use of CGM in GDM&#44; the GV data obtained as a predictive tool for the onset of obstetric and perinatal complications have provided mixed results&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">In GDM treatment&#44; hygienic dietary measures have been shown to reduce excess weight in newborns&#44; and there has been a drop in maternal-fetal complications when pharmacological treatment is administered&#46;<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">16&#8211;18</span></a> In terms of CGM in GDM and pharmacological treatment&#44; some studies have shown that when CGM is used&#44; more patients start pharmacological treatment than when only SMCG is used&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> However&#44; so far no study has analyzed the use of CGM following GDM diagnosis to detect GV parameters and their relation to the probability of requiring pharmacological treatment&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The aim of our study was to use CGM&#44; on diagnosis of GDM&#44; to establish whether mean glycemia levels and GV parameters can help predict the probability of a patient requiring pharmacological treatment&#44; and whether these parameters are related to the development of obstetric and perinatal complications&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Materials and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Patients</span><p id="par0035" class="elsevierStylePara elsevierViewall">This is a prospective study of GDM patients at the Endocrinology and Pregnancy Department of the University Hospital of Jerez&#44; Spain&#46; The inclusion period ran from February 2016 to June 2018&#46; This hospital provides coverage to 456&#44;000 inhabitants&#44; with an average of 2421 term pregnancies a year&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">The study included pregnant women between weeks 26 and 32 of gestation diagnosed with GDM using the two-step strategy&#44; and an oral glucose overload of 100&#8239;g with two abnormally high values&#44; in line with diagnostic criteria of the National Diabetes Data Group and the 3<span class="elsevierStyleSup">rd</span> Workshop-Conference on Gestational Diabetes Mellitus&#44; which are&#58; basal glucose 105&#8239;mg&#47;dL&#44; 190&#8239;mg&#47;dL at 60&#8239;minutes&#44; 165&#8239;mg&#47;dL at 120&#8239;minutes&#44; and 145&#8239;mg&#47;dl at 180&#8239;minutes&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a> Excluded from the study were those patients with pre-gestational diabetes&#44; chronic systemic illnesses&#44; an acute infectious process and&#47;or refusal to give informed consent&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">In the first visit following GDM diagnosis&#44; data were obtained from the patient on race&#44; age&#44; gestation stage&#44; family history of DM and personal GDM antecedents&#44; obstetric history&#44; pre-gestational body mass index &#40;pBMI&#41; and the following analytical parameters&#58; glucose&#44; HbA1c&#44; uric acid&#44; triglycerides&#44; HDL and LDL cholesterol&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">After completing gestation&#44; data were gathered on GDM treatment and maternal complications during gestation&#44; such as hypertension induced by pregnancy &#40;systolic arterial pressure &#8805;140&#8239;mm Hg or diastolic arterial pressure &#8805;90&#8239;mm Hg after 20 weeks of gestation&#41;&#44; pre-eclampsia &#40;hypertension induced by pregnancy&#44; with proteinuria &#8805;30&#8239;mg&#47;mmol creatinine&#41;&#44; type of birth &#40;ectopic&#44; instrumental delivery or caesarean&#41;&#46; The data on newborns included their weight at birth&#44; neonatal complications such as being small for gestational age &#40;SGA&#41; &#40;percentile &#60;10&#41;&#44; large for gestational age &#40;LGA&#41; &#40;percentile &#62;90&#41;&#44; macrosomia &#40;weight &#62;4000&#8239;g&#41;&#44; hypoglycemia &#40;less than 40&#8239;mg&#47;dl in the first 24&#8239;hours&#41;&#44; hyperbilirubinemia&#44; traumatism&#44; infection and length of stay in ICU&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Hygienic dietary measures</span><p id="par0055" class="elsevierStylePara elsevierViewall">In the first visit&#44; all patients were given advice on diet and a personalized plan based on their pBMI&#58; if this was less than 18&#46;5&#8239;kg&#47;m<span class="elsevierStyleSup">2</span>&#44; the dietary allowance was between 36&#8211;40&#8239;kcal&#47;kg&#47;day&#44; 31&#8211;35&#8239;kcal&#47;kg&#47;day at 18&#46;5&#8211;25&#8239;kg&#47;m<span class="elsevierStyleSup">2</span>&#44; 25&#8211;30&#8239;kcal&#47;&#47;kg&#47;day at 25&#8211;29&#8239;kg&#47;m<span class="elsevierStyleSup">2</span>&#44; and 23&#8211;25&#8239;kcal&#47;kg&#47;day if higher than 30&#8239;kg&#47;m<span class="elsevierStyleSup">2</span>&#46; The macronutrient distribution was 40&#37;&#8211;50&#37; carbohydrates&#44; 30&#37;&#8211;40&#37; fat and 20&#37; proteins&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Monitoring of glucose and treatment</span><p id="par0060" class="elsevierStylePara elsevierViewall">In the first visit&#44; according to routine clinical practice&#44; each woman was given a capillary glycemia monitoring device &#40;Contour&#174; next&#41; to perform SMCG before&#44; and 1&#8239;hour after&#44; breakfast&#44; lunch and dinner&#46; The marked glycemic targets follows the American Diabetes Association guidelines of &#8804;95&#8239;mg&#47;dl before eating&#44; &#8804;140&#8239;mg&#47;dl 1&#8239;hour after&#46;<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a> If this score was exceeded&#44; pharmacological treatment was started&#44; with insulin as the medium of choice in our setting for treatment by gestating mothers&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> Hypoglycemia was defined as a value of glucose &#60;70&#8239;mg&#47;dl&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">The first visit also included implanting a blind or retrospective CGM device in each patient &#40;model iPro&#8482;2&#41; that they would wear for 6 consecutive days&#46; The sensor was inserted into the subcutaneous tissue and linked to a transmitter attached to the skin&#46; This device records and stores 288 glucose measurements continuously over 24&#8239;hours&#44; and the data are downloaded for later assessment&#46; The parameters analyzed were&#58; mean glycemia as centralized measurement and mean GV&#44; standard deviation &#40;SD&#41;&#44; coefficient variance &#40;CV&#41;&#44; mean amplitude of glycemic excursions &#40;MAGE&#41;&#44; mean of daily differences &#40;MODD&#41; and continuous overlapping of net glycemic action in a period of n-hours &#40;CONGAn&#41;&#46; CV is defined as the SD divided by the glucose mean&#44; its interpretation expressed in percentage terms&#59; MAGE is defined as the arithmetic mean of glucose values from the lowest to the highest points or vice versa&#59; MODD is defined as the mean of the differences between glucose values at the same time of day over two consecutive days&#44; allowing the analysis of GV between different days&#44; and&#44; CONGA&#44; is the standard deviation of the sum of differences between a given value and the observed values in the previous hours &#40;n&#41;&#44; which enables the analysis of GV over a 24-h period&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">This study was approved by the Research Ethics Committee of the province of Cadiz in line with the ethical principles set out in the Helsinki Declaration&#46; Prior to inclusion in the study&#44; all patients wishing to participate signed an informed consent form&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Statistical analysis</span><p id="par0075" class="elsevierStylePara elsevierViewall">In the descriptive analysis&#44; the results of the quantitative variables were expressed in terms of mean and standard deviation&#44; and in frequencies and percentages for the qualitative variables&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">A multivariate analysis was performed using logistic regression models&#44; taking as dependent variables each result for obstetrics and newborns&#59; independent variables were mean glycemia&#44; SD&#44; CV&#44; MAGE&#44; MODD and CONGAn&#44; with age and pBMI used in the models as adjustment variables&#46; Then&#44; an analysis was made of the need for treatment&#44; as a dependent variable&#44; as well as using as the GV parameters mentioned as independent variables&#44; and adjusting for age and pBMI&#46; When the variables associated to the need for pharmacological treatment had been identified &#40;mean glycemia and CONGAn&#41;&#44; the area below the ROC curve was calculated for both variables&#46; A statistically significant association was confirmed if the p-value was less than 0&#46;05&#46; The Stata program version 16 was used to gather and analyze the data&#46; The GV parameters were calculated with EasyGV software&#46;<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">22&#44;23</span></a></p></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Results</span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Clinical characteristics&#44; anthropometric and analytical parameters</span><p id="par0085" class="elsevierStylePara elsevierViewall">The study initially included 87 patients with GDM&#44; but 10 were excluded due to problems with the sensor &#40;sensor damage or incomplete data transfer&#41;&#46; The analysis was carried out on 77 gestating mothers&#44; of whom 75 &#40;97&#46;4&#37;&#41; were classified as Caucasian&#44; 1 &#40;1&#46;4&#37;&#41;&#44; Asian and 1 &#40;1&#46;4&#37;&#41; Hispanic American&#46; The mean age was 33&#46;5&#8239;&#177;&#8239;4&#46;23 years &#40;30 patients &#91;38&#46;9&#37;&#93; were aged 35 or over&#41;&#46; GDM diagnosis was made at 30&#46;2&#8239;&#177;&#8239;2&#46;16 of gestation&#46; DM family antecedents were present in 51 &#40;66&#46;2&#37;&#41; of the patients&#46; Of all the patients analyzed&#44; 54 &#40;70&#46;1&#37;&#41; had had one or more prior pregnancies&#44; and of these 15 &#40;27&#46;7&#37;&#41; had presented with GDM in previous pregnancies&#46; The anthropometric and analytical parameters are presented in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Evolution of gestation&#44; birth and maternal-fetal complications</span><p id="par0090" class="elsevierStylePara elsevierViewall">During gestation&#44; 18 &#40;23&#46;4&#37;&#41; patients required pharmacological treatment with insulin&#44; administered in accordance with our area&#8217;s action protocol&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> On average&#44; treatment with insulin began in week 31 of gestation&#44; requiring a total insulin dose &#40;ID&#41; of 16&#46;8&#8239;&#177;&#8239;13&#46;72 &#40;IU&#41; corresponding to 0&#46;25 units per kilo of weight required per day &#40;ID&#47;kg&#47;day&#41;&#46; The type of insulin required was 33&#37; basal&#44; 33&#37; rapid acting analog&#44; and 33&#37; combined basal and rapid acting analog&#46; The most frequent time to administer insulin was before the 3 main meals of the day &#40;n&#8239;&#61;&#8239;8&#44; 44&#46;4&#37;&#41;&#44; then at around dinner time &#40;n&#8239;&#61;&#8239;5&#44; 27&#46;7&#37;&#41;&#59; less frequent administration occurred at breakfast and lunch &#40;n&#8239;&#61;&#8239;2&#44; 11&#46;1&#37;&#41;&#44; lunch and dinner &#40;n&#8239;&#61;&#8239;1&#46; 5&#46;5&#37;&#41; and breakfast &#40;n&#8239;&#61;&#8239;1&#46; 5&#46;5&#37;&#41;&#46;</p><p id="par0095" class="elsevierStylePara elsevierViewall">Regarding maternal complications during pregnancy&#44; 2 &#40;2&#46;6&#37;&#41; women developed gestational hypertension but none pre-eclampsia&#59; 44 &#40;57&#46;1&#37;&#41; patients had an ectopic birth&#44; 8 &#40;10&#46;4&#37;&#41; an instrumental delivery and 25 &#40;32&#46;5&#37;&#41; were by caesarean&#46;</p><p id="par0100" class="elsevierStylePara elsevierViewall">In the perinatal results&#44; the mean weight of the newborn was 3281&#46;7&#8239;&#177;&#8239;460&#46;68&#8239;grams &#40;percentile 56&#46;39&#8239;&#177;&#8239;30&#46;58&#41;&#44; 5 &#40;6&#46;5&#37;&#41; were SGA&#44; 14 &#40;18&#46;2&#37;&#41; LGA and 10 &#40;13&#37;&#41; had macrosomia&#46; A total of 17 &#40;22&#46;1&#37;&#41; newborns experienced a hypoglycemic episode&#44; 6 &#40;7&#46;8&#37;&#41; hyperbilirubinemia&#44; 6 &#40;7&#46;8&#37;&#41; required oxygen therapy support&#44; 1 &#40;1&#46;3&#37;&#41; suffered an obstetric traumatism&#44; 1 &#40;2&#46;3&#37;&#41; was born with an infection&#44; and 3 &#40;3&#46;9&#37;&#41; were admitted to ICU&#46;</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Continuous glucose monitoring</span><p id="par0105" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> presents the GV parameters based on the results from retrospective CGM over 6 consecutive days&#46; As observed in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#44; no relation was found between the various GV parameters and the obstetric and perinatal results&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0110" class="elsevierStylePara elsevierViewall">When assessing the relation between pharmacological treatment and GV parameters obtained from the CGM&#44; we observe that when mean glycemia and CONGAn levels are high&#44; the probability of the patient requiring pharmacological treatment increases with OR&#8239;&#61;&#8239;1&#46;24 for mean glycemia &#40;95&#37; confidence interval &#91;110&#8211;1&#46;40&#93;&#59; p&#8239;&#60;&#8239;0&#46;001&#93;&#41; and OR&#8239;&#61;&#8239;1&#46;22 for CONGAn &#40;95&#37; confidence interval &#91;1&#46;09&#8211;1&#46;37&#93;&#59; p&#8239;&#61;&#8239;0&#46;001&#93;&#41;&#46; Thus&#44; if we describe the data in terms of averages&#44; we observe that for each mg&#47;dL increase in mean glycemia and CONGAn&#44; there is a rise of 24&#37; and 22&#37; respectively in the probability of the patient requiring pharmacological treatment &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#41;&#46;</p><p id="par0115" class="elsevierStylePara elsevierViewall">In terms of the capacity to predict the need for pharmacological treatment based on CGM data&#44; the cut-off points for mean glycemia and CONGAn can be calculated with greater sensitivity &#40;S&#41; and specificity &#40;E&#41;&#44; with scores of 98&#46;81&#8239;mg&#47;dL &#40;S 83&#46;3&#37;&#44; E 67&#46;8&#37;&#41; and 86&#46;70&#8239;mg&#47;dL &#40;S 83&#46;3&#37;&#44; E 67&#46;8&#37;&#41;&#44; respectively &#40;<a class="elsevierStyleCrossRefs" href="#fig0005">Figs&#46; 1 and 2</a>&#41;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia></span></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conclusion</span><p id="par0120" class="elsevierStylePara elsevierViewall">The GV parameters obtained from CGM quantify the amplitude&#44; frequency and duration of glycemic fluctuations in a way that provides very useful information to add to that acquired by classic methods such as preprandial and postprandial glycemia readings from SMCG and HbA1c&#46; For this reason&#44; GV is increasingly important in the control of type 1 and 2 DM&#44; as it has demonstrated that the time and amplitude of glucose fluctuations imply greater risk of hyperglycemia and hypoglycemia&#46; GV itself is also known to represent a risk factor for diabetes-related complications&#46;<a class="elsevierStyleCrossRefs" href="#bib0120"><span class="elsevierStyleSup">24&#44;25</span></a></p><p id="par0125" class="elsevierStylePara elsevierViewall">In recent years&#44; CGM studies on GDM have also begun measuring GV parameters and analyzing their relation to maternal-fetal complications&#46; Given the scarcity of such studies&#44; there are still no established standardized GV reference values for GDM as there are for DM&#46;<a class="elsevierStyleCrossRefs" href="#bib0130"><span class="elsevierStyleSup">26&#8211;30</span></a> Another drawback is disparity in the results and the difficulty in comparing them&#44; as they do not always analyze the same GV parameters<a class="elsevierStyleCrossRefs" href="#bib0130"><span class="elsevierStyleSup">26&#8211;28</span></a>&#59; in addition&#44; the parameters are determined at different stages of gestation and different software programs are used in the calculations<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a>&#59; our study used the EasyGV software&#46;<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">22&#44;23</span></a> Yet although it is difficult to compare our results to those in other published studies&#44; it can be stated that the majority present GV values that are higher than those obtained in our work&#46;<a class="elsevierStyleCrossRefs" href="#bib0130"><span class="elsevierStyleSup">26&#8211;30</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall">Dietary treatment is the first therapeutic step&#44; and has been shown to reduce excess weight in newborns associated to GDM&#46;<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">31</span></a> Adequate glycemic control is achieved in 70&#37;&#8211;85&#37; of cases&#44; thus avoiding the need for pharmacological treatment&#46; The results in our study show that 23&#46;4&#37; of gestating mothers needed pharmacological treatment with insulin&#44; similar to that described in the literature&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> In patients who failed to reach the glycemia objectives by dietary treatment&#44; pharmacological treatment helps to reduce maternal-fetal complications&#44;<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">31</span></a> so it is essential to identify as soon as possible those patients who will probably need to it&#46;</p><p id="par0135" class="elsevierStylePara elsevierViewall">According to the latest data&#44; there are still no studies that aim to assess the relation between mean glycemia and GV after the diagnosis of GDM and the probability of requiring pharmacological treatment during the pregnancy&#46; Our study is the first to show that mean glycemia&#44; as a centralized measurement&#44; and CONGAn&#44; as a GV parameter&#44; both obtained by CGM after the diagnosis of GDM&#44; can help predict the need for pharmacological treatment&#46; In this way&#44; we observe that for each mg&#47;dL increase in mean glycemia and CONGAn&#44; there is a rise of 24&#37; and 22&#37; respectively in the probability of the patient requiring pharmacological treatment&#46;</p><p id="par0140" class="elsevierStylePara elsevierViewall">The results of our work enable us to establish cut-off points for mean glycemia and CONGAn with a high degree of sensitivity and specificity &#40;<a class="elsevierStyleCrossRefs" href="#fig0005">Figs&#46; 1 and 2</a>&#41;&#46; GDM patients require highly sensitive tests in order for medical professionals to intensify therapeutic measures quickly to prevent or minimize maternal-fetal complications&#46; Those patients detected with GDM via CGM with a mean glycemia above 98&#46;81&#8239;mg&#47;dL and&#47;or CONGAn higher than 86&#46;70&#8239;mg&#47;dL should be monitored more closely&#46; Thus&#44; it is possible to predict from diagnosis which patients will go on to require pharmacological treatment&#46;</p><p id="par0145" class="elsevierStylePara elsevierViewall">Another important finding in this work is the absence of any relation between the data for mean glycemia and GV obtained in GDM diagnosis and the development of maternal-fetal complications&#46; Several works have analyzed GV in GDM with different results&#46; One study of women with GDM in the third trimester corroborates our results&#44; as it did not find that CGM was a predictor of the development of complications in the mother or newborn&#44; though the number of patients included in the study was less than in ours&#46;<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a> By contrast&#44; another study shows a direct relation between GV and fetal growth in patients with type 1 diabetes and GDM &#40;at different stages of gestation&#41; but it analyzed only a small number of patients&#44; thus interpretation of the results is fairly inconsistent&#46;<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a> A more recent prospective observational study of GDM patients between weeks 30&#8211;32 of gestation showed a direct proportional relation between mean glycemia and LGA&#46;<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">30</span></a> In our study&#44; CGM was applied directly after diagnosing GDM&#44; and the patients received appropriate pharmacological treatment during monitoring&#44; with the consequent optimization of glycemic control yielding a reduction of the effect on the fetus and development of complications&#46;</p><p id="par0150" class="elsevierStylePara elsevierViewall">The novel aspect of this work is to demonstrate the potential usefulness of CGM on diagnosis of GDM as a tool that can identify a specific group of patients who would benefit from closer monitoring of mean glycemia and CONGAn&#44; and the cut-off points with high sensitivity&#46; So far&#44; there is no published work that assesses GV via CGM in the meaning presented in this study&#46; It also has the added value of homogeneity in the sample characteristics and the acceptable number of patients included&#46; The results obtained can be transferred to populations with characteristics similar to those in our sample&#44; although to extrapolate them would require future studies to recruit more patients&#46;</p><p id="par0155" class="elsevierStylePara elsevierViewall">One of the limitations of this study is the small number of patients included&#44; which can undermine the strength of this work to assess the potential relation to low-incidence obstetric and newborn results&#44; though this is still stronger than in the majority of works in the literature&#46; Another potential weakness is that compliance with dietary measures was irregular among the patients&#44; which could have affected the measurements as it is difficult to assess adherence to dietary advice&#46; Nevertheless&#44; this is unlikely to have had a significant effect since this is a highly homogeneous population with similar dietary habits marked by custom and place of residence&#46;</p><p id="par0160" class="elsevierStylePara elsevierViewall">In conclusion&#44; the use of CGM after GDM diagnosis can predict the probability of requiring pharmacological treatment in patients who present higher mean glycemia and CONGAn scores&#46; In this way&#44; CGM could identify those patients who would benefit from closer monitoring during gestation&#44; using SMCG in order to start pharmacological treatment as soon as a possible&#46; It would be interesting for future prospective studies to assess the efficiency of CGM&#44; that is&#44; to be able to show a reduction in maternal-fetal complications and associated costs in order for its use to be recommended following GDM diagnosis&#46;</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Conflict of interest</span><p id="par0165" class="elsevierStylePara elsevierViewall">The authors declares that they have no conflict of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres2149173"
          "titulo" => "Abstract"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Introduction"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Materials and methods"
            ]
            2 => array:2 [
              "identificador" => "abst0011"
              "titulo" => "Results"
            ]
            3 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1824150"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres2149174"
          "titulo" => "Resumen"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Objetivo"
            ]
            1 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "M&#233;todos"
            ]
            2 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "Resultados"
            ]
            3 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Conclusiones"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec1824151"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Materials and methods"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Patients"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Hygienic dietary measures"
            ]
            2 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "Monitoring of glucose and treatment"
            ]
            3 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "Statistical analysis"
            ]
          ]
        ]
        6 => array:3 [
          "identificador" => "sec0035"
          "titulo" => "Results"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0040"
              "titulo" => "Clinical characteristics&#44; anthropometric and analytical parameters"
            ]
            1 => array:2 [
              "identificador" => "sec0045"
              "titulo" => "Evolution of gestation&#44; birth and maternal-fetal complications"
            ]
            2 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Continuous glucose monitoring"
            ]
          ]
        ]
        7 => array:2 [
          "identificador" => "sec0055"
          "titulo" => "Conclusion"
        ]
        8 => array:2 [
          "identificador" => "sec0065"
          "titulo" => "Conflict of interest"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2023-08-28"
    "fechaAceptado" => "2023-12-28"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1824150"
          "palabras" => array:5 [
            0 => "Continuous glucose monitoring"
            1 => "Glycemic variability"
            2 => "Gestational diabetes mellitus"
            3 => "Pharmacological treatment"
            4 => "Maternal-fetal complications"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1824151"
          "palabras" => array:5 [
            0 => "Monitorizaci&#243;n continua de glucosa"
            1 => "Variabilidad gluc&#233;mica"
            2 => "Diabetes mellitus gestacional"
            3 => "Tratamiento farmacol&#243;gico"
            4 => "Complicaciones materno-fetales"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">To establish whether glycemic variability &#40;GV&#41; parameters used when gestational diabetes mellitus &#40;GDM&#41; has been diagnosed could help predict the probability that a patient will need pharmacological treatment&#44; and to analyze the link of these parameters to the development of maternal-fetal complications&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Materials and methods</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">A prospective study of 87 women with GDM who underwent retrospective continuous glucose monitoring &#40;CGM&#41; for six days between weeks 26 and 32 of gestation&#44; following diagnosis&#46; The mean glycemia levels and GV variables were analyzed together with their link to maternal-fetal complications&#44; and the need for pharmacological treatment&#46; ROC &#40;receiver operating characteristic&#41; curves were developed to determine validity to detect the need for pharmacological treatment&#46;</p></span> <span id="abst0011" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0011">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Patients with higher mean glycemia &#40;p&#8239;&#60;&#8239;0&#46;001&#41; and continuous overlapping of net glycemic action in a period of n-hours &#40;CONGAn&#41; &#40;p&#8239;&#61;&#8239;0&#46;001&#41; required pharmacological treatment&#46; The ROC curves showed cut-off points of 98&#46;81&#8239;mg&#47;dL for mean glycemia&#44; and 86&#46;70&#8239;mg&#47;dL for CONGAn&#44; with 83&#46;3&#37; sensitivity and 67&#46;8&#37; specificity for both parameters&#46; No relation between the GV parameters and development of maternal-fetal complications was observed&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">The use of CGM&#44; once GDM is diagnosed&#44; enables us to identify those patients who would benefit from closer monitoring during gestation&#44; and facilitate a speedier take-up of pharmacological treatment&#46; However&#44; prospective studies involving a higher number of patients are needed&#44; as well as a cost assessment for recommending the use of CGM following GDM diagnosis&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Introduction"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Materials and methods"
          ]
          2 => array:2 [
            "identificador" => "abst0011"
            "titulo" => "Results"
          ]
          3 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Conclusions"
          ]
        ]
      ]
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Objetivo</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Establecer si determinados par&#225;metros de variabilidad gluc&#233;mica &#40;VG&#41; al diagn&#243;stico de Diabetes Mellitus gestacional &#40;DMG&#41; podr&#237;an ayudar a predecir la probabilidad de precisar tratamiento farmacol&#243;gico y analizar la relaci&#243;n de estos con el desarrollo de complicaciones materno-fetales&#46;</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">M&#233;todos</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Estudio prospectivo en 87 mujeres con DMG a las que se realiza una monitorizaci&#243;n continua de glucosa &#40;MCG&#41; retrospectiva entre la 26-32 semana de gestaci&#243;n durante 6 d&#237;as&#44; tras el diagn&#243;stico&#46; Se analizan glucemia media y par&#225;metros de VG y su asociaci&#243;n con complicaciones materno-fetales y necesidad de tratamiento farmacol&#243;gico&#46; Se elaboran curvas ROC para estimar la validez para detectar la necesidad de tratamiento farmacol&#243;gico&#46;</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Resultados</span><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Las pacientes con glucemia media m&#225;s elevada &#40;p&#8239;&#60;&#8239;0&#46;001&#41; y solapamiento continuo de la acci&#243;n de la glucosa en un periodo de n-horas &#40;CONGA&#41; &#40;p&#8239;&#61;&#8239;0&#46;001&#41; precisaron tratamiento farmacol&#243;gico&#46; A partir de las curvas ROC se obtuvieron los puntos de corte de 98&#46;81&#8239;mg&#47;dL para glucemia media y de 86&#46;70&#8239;mg&#47;dL para CONGA con una sensibilidad de 83&#46;3&#37;&#37; y especificidad de 67&#46;8&#37; para ambos par&#225;metros&#46; No se observ&#243; una relaci&#243;n entre los distintos par&#225;metros de VG y el desarrollo de complicaciones materno-fetales&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Conclusiones</span><p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">El uso de la MCG al diagn&#243;stico de la DMG permite identificar a aquellas pacientes que se beneficiar&#237;an de una vigilancia m&#225;s estrecha durante la gestaci&#243;n&#44; facilitando el inicio de un tratamiento farmacol&#243;gico precoz&#46; No obstante&#44; son necesarios estudios prospectivos con un mayor n&#250;mero de pacientes y que eval&#250;en los costes asociados para poder recomendar el uso de la MCG tras el diagn&#243;stico de DMG&#46;</p></span>"
        "secciones" => array:4 [
          0 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Objetivo"
          ]
          1 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "M&#233;todos"
          ]
          2 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "Resultados"
          ]
          3 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Conclusiones"
          ]
        ]
      ]
    ]
    "multimedia" => array:4 [
      0 => array:8 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 917
            "Ancho" => 1258
            "Tamanyo" => 78850
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0005"
            "detalle" => "Figure "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">ROC curve for mean glycemia and pharmacological treatment&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 977
            "Ancho" => 1341
            "Tamanyo" => 87725
          ]
        ]
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0010"
            "detalle" => "Figure "
            "rol" => "short"
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">ROC curve for CONGA and pharmacological treatment&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0015"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Variables&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Value &#40;mean&#8239;&#177;&#8239;SD&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pregestation weight &#40;kg&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">69&#46;6&#8239;&#177;&#8239;12&#46;46&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pregestation BMI &#40;kg&#47;m<span class="elsevierStyleSup">2</span>&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">26&#46;2&#8239;&#177;&#8239;4&#46;75&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pregestation obesity &#40;BMI&#8239;&#62;&#8239;30&#8239;kg&#47;m<span class="elsevierStyleSup">2</span>&#41; &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">17 &#40;22&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Weight gain&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#46;1&#8239;&#177;&#8239;5&#46;14&#8239;kg&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Oral glucose overload 50&#8239;g 60&#8239;min &#40;mg&#47;dl&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">172&#46;3&#8239;&#177;&#8239;19&#46;73&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Oral glucose overload 100&#8239;g 0&#8239;min &#40;mg&#47;dl&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">80&#46;9&#8239;&#177;&#8239;11&#46;47&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Oral glucose overload 100&#8239;g 60&#8239;min &#40;mg&#47;dl&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">193&#46;8&#8239;&#177;&#8239;22&#46;45&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Oral glucose overload 100&#8239;g 120&#8239;min &#40;mg&#47;dl&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">180&#46;1&#8239;&#177;&#8239;22&#46;03&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Oral glucose overload 100&#8239;g 180&#8239;min &#40;mg&#47;dl&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">146&#46;6&#8239;&#177;&#8239;29&#46;88&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Total cholesterol &#40;mg&#47;dl&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">243&#46;3&#8239;&#177;&#8239;43&#46;14&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">LDL cholesterol &#40;mg&#47;dl&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">151&#46;9&#8239;&#177;&#8239;43&#46;84&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HDL cholesterol HDL &#40;mg&#47;dl&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">68&#46;4&#8239;&#177;&#8239;26&#46;89&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Triglycerides &#40;mg&#47;dl&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">211&#46;4&#8239;&#177;&#8239;68&#46;75&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Uric acid &#40;mg&#47;dl&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#46;1&#8239;&#177;&#8239;3&#46;65&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HbA1c&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&#46;1&#8239;&#177;&#8239;0&#46;33&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mean&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">97&#46;4&#8239;&#177;&#8239;8&#46;40&#8239;mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19&#46;6&#8239;&#177;&#8239;4&#46;30&#8239;mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">CV&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">20&#46;1&#8239;&#177;&#8239;4&#46;30 &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">MAGE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">44&#46;2&#8239;&#177;&#8239;13&#46;43&#8239;mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">MODD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19&#46;7&#8239;&#177;&#8239;5&#46;39&#8239;mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">CONGA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">85&#46;8&#8239;&#177;&#8239;7&#46;69&#8239;mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab3541891.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Analytical &#38; anthropometric parameters&#46;</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Table 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at0020"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Treatment&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Caesarean&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Macrosomia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">LGA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Hypoglycemia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mean&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;24 &#91;0&#46;09&#8211;0&#46;34&#93;&#60;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;98 &#91;0&#46;93&#8211;1&#46;05&#93;p&#8239;&#61;&#8239;0&#46;739&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;03 &#91;0&#46;95&#8211;1&#46;13&#93;p&#8239;&#61;&#8239;0&#46;398&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;07 &#91;0&#46;99&#8211;1&#46;16&#93;p&#8239;&#61;&#8239;0&#46;104&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#91;0&#46;93&#8211;1&#46;07&#93;p&#8239;&#61;&#8239;0&#46;935&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">SD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;11 &#91;&#8722;0&#46;03 to 0&#46;25&#93;p&#8239;&#61;&#8239;0&#46;121&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;96 &#91;0&#46;85&#8211;1&#46;08&#93;p&#8239;&#61;&#8239;0&#46;477&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;96 &#91;0&#46;81&#8211;1&#46;13&#93;p&#8239;&#61;&#8239;0&#46;629&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;04 &#91;0&#46;90&#8211;1&#46;19&#93;p&#8239;&#61;&#8239;0&#46;579&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;99 &#91;0&#46;86&#8211;1&#46;13&#93;p&#8239;&#61;&#8239;0&#46;839&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">CV&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;99 &#91;0&#46;86&#8211;1&#46;14&#93;p&#8239;&#61;&#8239;0&#46;890&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;96 &#91;0&#46;84&#8211;1&#46;09&#93;p&#8239;&#61;&#8239;0&#46;540&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;93 &#91;0&#46;79&#8211;1&#46;11&#93;p&#8239;&#61;&#8239;0&#46;444&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#91;0&#46;88&#8211;1&#46;16&#93;p&#8239;&#61;&#8239;0&#46;970&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;98 &#91;0&#46;85 &#8211; 1&#46;12&#93;p&#8239;&#61;&#8239;0&#46;743&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">MAGE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;03 &#91;&#8722;0&#46;01 to 0&#46;07&#93;p&#8239;&#61;&#8239;0&#46;176&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;99 &#91;0&#46;95&#8211;1&#46;03&#93;p&#8239;&#61;&#8239;0&#46;612&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;99 &#91;0&#46;94&#8211;1&#46;05&#93;p&#8239;&#61;&#8239;0&#46;943&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;03 &#91;0&#46;98&#8211;1&#46;08&#93;p&#8239;&#61;&#8239;0&#46;197&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;99 &#91;0&#46;96&#8211;1&#46;04&#93;p&#8239;&#61;&#8239;0&#46;900&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">MODD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;96 &#91;&#8722;0&#46;01 to 0&#46;20&#93;p&#8239;&#61;&#8239;0&#46;075&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;95 &#91;0&#46;85&#8211;1&#46;04&#93;p&#8239;&#61;&#8239;0&#46;294&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;98 &#91;0&#46;86&#8211;1&#46;12&#93;p&#8239;&#61;&#8239;0&#46;790&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#91;0&#46;93&#8211;1&#46;15&#93;p&#8239;&#61;&#8239;0&#46;556&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;96 &#91;0&#46;86&#8211;1&#46;07&#93;p&#8239;&#61;&#8239;0&#46;503&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">CONGA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;22 &#91;0&#46;08&#8211;0&#46;31&#93;p&#8239;&#61;&#8239;0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#46;99 &#91;0&#46;93&#8211;1&#46;07&#93;&#59;p&#8239;&#61;&#8239;0&#46;990&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;04 &#91;0&#46;94&#8211;1&#46;14&#93;p&#8239;&#61;&#8239;0&#46;425&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;07 &#91;0&#46;98&#8211;1&#46;16&#93;p&#8239;&#61;&#8239;0&#46;144&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#91;0&#46;93&#8211;1&#46;08&#93;p&#8239;&#61;&#8239;0&#46;879&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab3541890.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Logistic regression analysis of the association between GV and maternal-fetal complications and treatment with insulin&#46; Odds ratio &#40;confidence interval 95&#37;&#41;&#44; p-value&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:31 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Classification and diagnosis of diabetes&#58; standards of medical care in diabetes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "American Diabetes Association Professional Practice Committee&#46; 2"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Diabetes Care"
                        "fecha" => "2023"
                        "volumen" => "46"
                        "numero" => "Supplement 1"
                        "paginaInicial" => "S2"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Potential impact of American Diabetes Association &#40;2000&#41; criteria for diagnosis of gestational diabetes mellitus in Spain"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "W&#46; Ricart"
                            1 => "J&#46; L&#243;pez"
                            2 => "J&#46; Mozas"
                            3 => "A&#46; Pericot"
                            4 => "M&#46;A&#46; Sancho"
                            5 => "N&#46; Gonz&#225;lez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00125-005-1756-9"
                      "Revista" => array:7 [
                        "tituloSerie" => "Diabetologia"
                        "fecha" => "2005"
                        "volumen" => "48"
                        "numero" => "6"
                        "paginaInicial" => "1135"
                        "paginaFinal" => "1141"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15889233"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Gestational diabetes mellitus and adverse pregnancy outcomes&#58; systematic review and meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "W&#46; Ye"
                            1 => "C&#46; Lou"
                            2 => "J&#46; Huang"
                            3 => "C&#46; Li"
                            4 => "Z&#46; Liu"
                            5 => "F&#46; Liu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bmj-2021-067946"
                      "Revista" => array:4 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2022"
                        "volumen" => "25"
                        "numero" => "377"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Gestational diabetes melltus and long-term consequences for mother and offspring&#58; a view fron Denbark"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "P&#46; Damm"
                            1 => "A&#46; Houshmand-Oeragaard"
                            2 => "L&#46; Kelstraup"
                            3 => "J&#46; Lauenborg"
                            4 => "E&#46;R&#46; Mathiesen"
                            5 => "T&#46;D&#46; Clausen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00125-016-3985-5"
                      "Revista" => array:6 [
                        "tituloSerie" => "Diabetologia"
                        "fecha" => "2016"
                        "volumen" => "59"
                        "paginaInicial" => "1396"
                        "paginaFinal" => "1399"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27174368"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "W&#46;L Lowe"
                            1 => "D&#46;M Scholtens"
                            2 => "L&#46;P Lowe"
                            3 => "A&#46; Kuang"
                            4 => "O&#46; Nodzenski"
                            5 => "O Talbot"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.2018.11628"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA"
                        "fecha" => "2018"
                        "volumen" => "320"
                        "paginaInicial" => "1005"
                        "paginaFinal" => "1016"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30208453"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diabetes mellitus gestacional proceso de atenci&#243;n integrado &#91;Internet&#93;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Forcada-Falc&#243;n"
                            1 => "L&#46; Aceituno-Velasco"
                            2 => "D&#46; Acosta-Delgado"
                            3 => "L&#46; Arribas-Mir"
                            4 => "P&#46; Aznarte-Padial"
                            5 => "C&#46; Candela-G&#243;mez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "WWW" => array:2 [
                        "link" => "http&#58;&#47;&#47;red&#46;pidma&#46;es&#47;file&#46;php&#47;1&#47;Doc&#95;Apoyo&#95;Diabetes&#95;Gestacionalv7&#46;pdf"
                        "fecha" => "2019"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sistema de monitorizaci&#243;n continua de glucosa&#58; una nueva herramienta para mejorar el control metab&#243;lico de los pacientes diab&#233;ticos"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46; Chico"
                            1 => "M&#46; Subir&#224;"
                            2 => "A&#46; Novials"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Endocrinol Nutr"
                        "fecha" => "2001"
                        "volumen" => "48"
                        "numero" => "9"
                        "paginaInicial" => "266"
                        "paginaFinal" => "271"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:1 [
                  "host" => array:1 [
                    0 => array:1 [
                      "Libro" => array:3 [
                        "titulo" => "Monitorizaci&#243;n continua de glucosa y monitorizaci&#243;n flash de glucosa"
                        "fecha" => "2019"
                        "editorial" => "Sociedad Espa&#241;ola de Diabetes"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Continuous glucose monitoring during pregnancy complicated by gestational diabetes mellitus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "L&#46; Jovanovic"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s11892-001-0015-9"
                      "Revista" => array:7 [
                        "tituloSerie" => "Curr Diab Rep"
                        "fecha" => "2001"
                        "volumen" => "1"
                        "numero" => "1"
                        "paginaInicial" => "82"
                        "paginaFinal" => "85"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12762962"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Introductory experience with the continuous glucose monitoring system &#40;CGMS&#59; Medtronic Minimed&#41; in detecting hyperglycemia by comparing the self-monitoring of blood glucose &#40;SMBG&#41; in non-pregnant women and in pregnant women with impaired glucose tolerance and gestational diabetes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;J&#46; B&#252;hling"
                            1 => "B&#46; Kurzidim"
                            2 => "C&#46; Wolf"
                            3 => "K&#46; Wohlfarth"
                            4 => "M&#46; Mahmoudi"
                            5 => "C&#46; W&#228;scher"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1055/s-2004-830399"
                      "Revista" => array:7 [
                        "tituloSerie" => "Exp Clin Endocrinol Diabetes"
                        "fecha" => "2004"
                        "volumen" => "112"
                        "numero" => "10"
                        "paginaInicial" => "556"
                        "paginaFinal" => "560"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15578329"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effects of continuous glucose monitoring on maternal and neonatal outcomes in perinatal women with diabetes&#58; a systematic reviedw and meta-analysis de randomized controlled trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "V&#46;Y&#46; Chang"
                            1 => "Y&#46;L Tan"
                            2 => "W&#46;H&#46;D Ang"
                            3 => "Y&#46; Lau"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Diabetes Res Clin Pract"
                        "fecha" => "2021"
                        "volumen" => "184"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy of continous glucose monitoring on glycaemic cotrol in pregnant women with gestational diabetes mellitus- a systematic review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "A&#46; Majewska"
                            1 => "P&#46;J&#46; Stanrowski"
                            2 => "M&#46; Wielgos"
                            3 => "C&#46; Bomba-Opos"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3390/jcm11071932"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Clin Med"
                        "fecha" => "2022"
                        "volumen" => "11"
                        "paginaInicial" => "1932"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35407540"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Measuring glucose exposure and variability using continuous glucose monitoring in normal and abnormal glucose metabolism in pregnancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46; Mazze"
                            1 => "Y&#46; Yogev"
                            2 => "O&#46; Langer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3109/14767058.2012.670413"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Matern Fetal Neonatal Med"
                        "fecha" => "2012"
                        "volumen" => "25"
                        "numero" => "7"
                        "paginaInicial" => "1171"
                        "paginaFinal" => "1175"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22384865"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Glycemic variability in gestacional diabetes mellitus and its assotiacion wit b cell function"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46;B&#46; Su"
                            1 => "X&#46;Q&#46; Wang"
                            2 => "J&#46;F&#46; Chen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s12020-012-9753-5"
                      "Revista" => array:7 [
                        "tituloSerie" => "Endocrine"
                        "fecha" => "2013"
                        "volumen" => "43"
                        "numero" => "2"
                        "paginaInicial" => "370"
                        "paginaFinal" => "375"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22815046"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A review of research progress of glycemic variability and gestational diabetes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "Y&#46; Wenshu"
                            1 => "W&#46; Na"
                            2 => "L&#46; Ling"
                            3 => "U&#46; Jong"
                            4 => "Q&#46; Meichen"
                            5 => "S&#46; Haitao"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Diabetes Metab Synd Obes"
                        "fecha" => "2020"
                        "volumen" => "13"
                        "paginaInicial" => "2729"
                        "paginaFinal" => "2741"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatments for women with gestational diabetes mellitus&#58; an overview of Cochrane systematic reviews"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "R&#46; Martis"
                            1 => "C&#46;A&#46; Crowther"
                            2 => "E&#46; Shepherd"
                            3 => "J&#46; Alsweiler"
                            4 => "M&#46;R&#46; Downie"
                            5 => "J&#46; Brown"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/14651858.CD012327.pub2"
                      "Revista" => array:3 [
                        "tituloSerie" => "Cochrane Database Syst Rev"
                        "fecha" => "2018"
                        "numero" => "8"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of treatment of gestational diabetes mellitus on pregnancy outcomes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;A&#46; Crowther"
                            1 => "J&#46;E&#46; Hiller"
                            2 => "J&#46;R&#46; Moss"
                            3 => "A&#46;J&#46; McPhee"
                            4 => "W&#46;S&#46; Jeffries"
                            5 => "J&#46;S&#46; Robinson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa042973"
                      "Revista" => array:7 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2005"
                        "volumen" => "352"
                        "numero" => "24"
                        "paginaInicial" => "2477"
                        "paginaFinal" => "2486"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15951574"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A multicenter&#44; randomized trial of treatment for mild gestational diabetes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;B&#46; Landon"
                            1 => "C&#46;Y&#46; Spong"
                            2 => "E&#46; Thom"
                            3 => "M&#46;W&#46; Carpenter"
                            4 => "S&#46;M&#46; Ramin"
                            5 => "B&#46; Casey"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa0902430"
                      "Revista" => array:7 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2009"
                        "volumen" => "361"
                        "numero" => "14"
                        "paginaInicial" => "1339"
                        "paginaFinal" => "1348"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19797280"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "K&#46;K&#46; Kestil&#228;"
                            1 => "U&#46;U&#46; Ekblad"
                            2 => "T&#46; R&#246;nnemaa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.diabres.2006.12.012"
                      "Revista" => array:7 [
                        "tituloSerie" => "Diabetes Res Clin Pract"
                        "fecha" => "2007"
                        "volumen" => "77"
                        "numero" => "2"
                        "paginaInicial" => "174"
                        "paginaFinal" => "179"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17234297"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Asistencia a la gestante con diabetes&#46; Gu&#237;a de pr&#225;ctica cl&#237;nica actualizada en 2014"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Grupo Espanol &#732; de Diabetes y Embarazo &#40;GEDE&#41;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Av Diabetol"
                        "fecha" => "2015"
                        "volumen" => "31"
                        "numero" => "2"
                        "paginaInicial" => "45"
                        "paginaFinal" => "59"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Management of diabetes in pregnancy&#58; standards of medical care in diabetes&#8212;2023"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Association AD&#46; 15"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Diabetes Care"
                        "fecha" => "2023"
                        "volumen" => "46"
                        "numero" => "Supplement 1"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "N&#46;R&#46; Hill"
                            1 => "N&#46;S&#46; Oliver"
                            2 => "P&#46; Choudhary"
                            3 => "J&#46;C&#46; Levy"
                            4 => "P&#46; Hindmarsh"
                            5 => "D&#46;R&#46; Matthews"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1089/dia.2010.0247"
                      "Revista" => array:7 [
                        "tituloSerie" => "Diabetes Technol Ther"
                        "fecha" => "2011"
                        "volumen" => "13"
                        "numero" => "9"
                        "paginaInicial" => "921"
                        "paginaFinal" => "928"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21714681"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Differences in the mean amplitude of glycemic excursions calculated by two automated methods"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "P&#46;I&#46; Beato-V&#237;bora"
                            1 => "F&#46;J&#46; Arroyo-D&#237;ez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1089/dia.2013.0195"
                      "Revista" => array:7 [
                        "tituloSerie" => "Diabetes Technol Ther"
                        "fecha" => "2014"
                        "volumen" => "16"
                        "numero" => "2"
                        "paginaInicial" => "123"
                        "paginaFinal" => "124"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24160691"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Glycemic variability&#58; the third component of the dysglycemia in diabetes&#46; Is it important&#63; How to measure it&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "L&#46; Monnier"
                            1 => "C&#46; Colette"
                            2 => "D&#46;R&#46; Owens"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/193229680800200618"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Diabetes Sci Technol"
                        "fecha" => "2008"
                        "volumen" => "2"
                        "numero" => "6"
                        "paginaInicial" => "1094"
                        "paginaFinal" => "1100"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19885298"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin&#46; Evidence and clinical perspectives"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "F&#46; Picconi"
                            1 => "A&#46; Di Flaviani"
                            2 => "I&#46; Malandrucco"
                            3 => "I&#46; Giordani"
                            4 => "S&#46; Frontoni"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.numecd.2012.03.006"
                      "Revista" => array:7 [
                        "tituloSerie" => "Nutr Metab Cardiovasc Dis"
                        "fecha" => "2012"
                        "volumen" => "22"
                        "numero" => "9"
                        "paginaInicial" => "691"
                        "paginaFinal" => "696"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22673768"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus&#58; a prospective cohort study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Yu"
                            1 => "L&#46; Lv"
                            2 => "Z&#46; Liang"
                            3 => "Y&#46; Wang"
                            4 => "J&#46; Wen"
                            5 => "X&#46; Lin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1210/jc.2013-4332"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Clin Endocrinol Metab"
                        "fecha" => "2014"
                        "volumen" => "99"
                        "numero" => "12"
                        "paginaInicial" => "4674"
                        "paginaFinal" => "4682"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25057872"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Glucose variability in diabetic pregnancy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;G&#46; Dalfr&#224;"
                            1 => "G&#46; Sartore"
                            2 => "G&#46; Di Cianni"
                            3 => "G&#46; Mello"
                            4 => "C&#46; Lencioni"
                            5 => "S&#46; Ottanelli"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1089/dia.2010.0145"
                      "Revista" => array:7 [
                        "tituloSerie" => "Diabetes Technol Ther"
                        "fecha" => "2011"
                        "volumen" => "13"
                        "numero" => "8"
                        "paginaInicial" => "853"
                        "paginaFinal" => "859"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21751862"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Correlation between third trimester glycemic variability in non-insulin-dependent gestational diabetes mellitus and adverse pregnancy and fetal outcomes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "W&#46;S&#46; Panyakat"
                            1 => "C&#46; Phatihattakorn"
                            2 => "A&#46; Sriwijitkamol"
                            3 => "P&#46; Sunsaneevithayakul"
                            4 => "A&#46; Phaophan"
                            5 => "A&#46; Phichitkanka"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1177/1932296817752374"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Diabetes Sci Technol"
                        "fecha" => "2018"
                        "volumen" => "12"
                        "numero" => "3"
                        "paginaInicial" => "622"
                        "paginaFinal" => "629"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29320884"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Glucose fluctuations during gestation&#58; an additional tool for monitoring pregnancy complicated by diabetes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;G&#46; Dalfr&#224;"
                            1 => "N&#46;C&#46; Chilelli"
                            2 => "G&#46; Di Cianni"
                            3 => "G&#46; Mello"
                            4 => "C&#46; Lencioni"
                            5 => "S&#46; Biagioni"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Int J Endocrinol"
                        "fecha" => "2013"
                        "volumen" => "2013"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "30"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Suboptimal nocturnal glucose control is associated with large for gestational age in treated gestational diabetes mellitus"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "G&#46;R&#46; Law"
                            1 => "A&#46; Alnaji"
                            2 => "L&#46; Alrefaii"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2337/dc18-2212"
                      "Revista" => array:6 [
                        "tituloSerie" => "Diabetes Care"
                        "fecha" => "2019"
                        "volumen" => "42"
                        "paginaInicial" => "810"
                        "paginaFinal" => "815"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30765428"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "31"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Lifestyle interventions for the treatment of women with gestational diabetes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Brown"
                            1 => "N&#46;A&#46; Alwan"
                            2 => "J&#46; West"
                            3 => "S&#46; Brown"
                            4 => "C&#46;J&#46; McKinlay"
                            5 => "D&#46; Farrar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:2 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Cochrane Database Syst Rev"
                        "fecha" => "2017"
                        "volumen" => "5"
                      ]
                    ]
                    1 => array:1 [
                      "WWW" => array:1 [
                        "link" => "https&#58;&#47;&#47;ws003&#46;juntadeandalucia&#46;es&#58;3071&#47;cdsr&#47;doi&#47;10&#46;1002&#47;14651858&#46;CD011970&#46;pub2&#47;abstract"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/25300180/0000007100000003/v2_202405192240/S253001802400026X/v2_202405192240/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "64496"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Original articles"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/25300180/0000007100000003/v2_202405192240/S253001802400026X/v2_202405192240/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S253001802400026X?idApp=UINPBA00004N"
]